| (+)-alpha-tocopherol | increases cleavage | ISO | RGD:69147 | 6480464 | alpha-Tocopherol analog results in increased cleavage of CASP9 protein | CTD | PMID:20686688 |
| (+)-catechin | increases activity | ISO | RGD:69147 | 6480464 | Catechin results in increased activity of CASP9 protein | CTD | PMID:20206613 |
| (+)-pilocarpine | increases expression | ISO | RGD:62159 | 6480464 | Pilocarpine results in increased expression of CASP9 protein | CTD | PMID:18708038 |
| (-)-anisomycin | multiple interactions | ISO | RGD:69147 | 6480464 | Anisomycin promotes the reaction [Indomethacin results in increased activity of CASP9 protein] | CTD | PMID:17341418 |
| (-)-citrinin | increases activity | ISO | RGD:62159 | 6480464 | Citrinin results in increased activity of CASP9 protein | CTD | PMID:21622943 |
| (-)-citrinin | increases expression | EXP | | 6480464 | Citrinin results in increased expression of CASP9 protein modified form | CTD | PMID:22564900 |
| (-)-epigallocatechin 3-gallate | increases activity | ISO | RGD:69147 | 6480464 | epigallocatechin gallate results in increased activity of CASP9 protein | CTD | PMID:15764647 |
| (-)-epigallocatechin 3-gallate | increases cleavage | ISO | RGD:69147 | 6480464 | epigallocatechin gallate analog results in increased cleavage of CASP9 protein | CTD | PMID:16115949 |
| (R)-lipoic acid | increases activity | ISO | RGD:69147 | 6480464 | Thioctic Acid results in increased activity of CASP9 protein | CTD | PMID:16990509 |
| (R)-lipoic acid | multiple interactions | EXP | | 6480464 | Thioctic Acid inhibits the reaction [Streptozocin results in increased expression of CASP9 protein] | CTD | PMID:19951573 |
| (R)-mevalonic acid | multiple interactions | ISO | RGD:69147 | 6480464 | Mevalonic Acid inhibits the reaction [Simvastatin results in increased cleavage of CASP9 protein] | CTD | PMID:20045437 |
| (R)-mevalonic acid | multiple interactions | EXP | | 6480464 | Mevalonic Acid inhibits the reaction [atorvastatin results in increased activity of CASP9 protein] | CTD | PMID:18339080 |
| (R)-noradrenaline | multiple interactions | EXP | | 6480464 | Ascorbic Acid inhibits the reaction [Norepinephrine results in increased activity of CASP9 protein]; more ... | CTD | PMID:15158148 |
| (R)-noradrenaline | increases activity | EXP | | 6480464 | Norepinephrine results in increased activity of CASP9 protein | CTD | PMID:15158148 PMID:14732211 |
| (R)-noradrenaline | increases cleavage | EXP | | 6480464 | Norepinephrine results in increased cleavage of CASP9 protein | CTD | PMID:16338971 |
| (R)-noradrenaline | increases activity | EXP | | 6480464 | Norepinephrine results in increased activity of CASP9 protein | CTD | PMID:14732211 PMID:15158148 |
| (S)-colchicine | increases activity | ISO | RGD:69147 | 6480464 | Colchicine results in increased activity of CASP9 protein | CTD | PMID:22342440 |
| (S)-naringenin | increases activity | ISO | RGD:69147 | 6480464 | naringenin results in increased activity of CASP9 protein | CTD | PMID:19124070 |
| (S)-nicotine | multiple interactions | ISO | RGD:69147 | 6480464 | Nicotine inhibits the reaction [[Cisplatin co-treated with Etoposide] results in increased activity of CASP9 protein] | CTD | PMID:18676776 |
| (S)-nicotine | decreases expression | ISO | RGD:69147 | 6480464 | Nicotine results in decreased expression of CASP9 mRNA | CTD | PMID:16949557 |
| (S)-nicotine | multiple interactions | ISO | RGD:62159 | 6480464 | [Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of CASP9 mRNA; more ... | CTD | PMID:20230807 |
| (S)-ropivacaine | decreases expression | ISO | RGD:69147 | 6480464 | ropivacaine results in decreased expression of CASP9 protein | CTD | PMID:20194319 |
| 1,4-dithiothreitol | multiple interactions | ISO | RGD:62159 | 6480464 | Dithiothreitol inhibits the reaction [2-methyl-3-(2-((4-nitrooxybutyloxy)carbonyl)vinyl)phenyl ursodeoxycholic acid ester results in decreased activity of CASP9 protein] | CTD | PMID:11226294 |
| 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | increases expression | ISO | RGD:62159 | 6480464 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of CASP9 mRNA | CTD | PMID:20230807 |
| 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | multiple interactions | ISO | RGD:62159 | 6480464 | [Caffeine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of CASP9 mRNA; more ... | CTD | PMID:20230807 |
| 17alpha-ethynylestradiol | multiple interactions | EXP | | 6480464 | [Gossypol co-treated with Methyltestosterone co-treated with Ethinyl Estradiol] results in increased expression of CASP9 mRNA | CTD | PMID:15451339 |
| 17beta-estradiol | multiple interactions | EXP | | 6480464 | ABCC8 protein promotes the reaction [Estradiol results in increased activity of CASP9 protein] | CTD | PMID:19095654 |
| 17beta-estradiol | decreases expression | ISO | RGD:69147 | 6480464 | Estradiol results in decreased expression of CASP9 mRNA | CTD | PMID:23373633 |
| 17beta-estradiol | increases activity | ISO | RGD:69147 | 6480464 | Estradiol results in increased activity of CASP9 protein | CTD | PMID:19095654 |
| 2,2',4,4',5,5'-hexachlorobiphenyl | increases activity | ISO | RGD:62159 | 6480464 | 2,4,5,2',4',5'-hexachlorobiphenyl results in increased activity of CASP9 protein | CTD | PMID:19362103 |
| 2,2',4,4',5,5'-hexachlorobiphenyl | increases expression | ISO | RGD:69147 | 6480464 | 2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of CASP9 protein | CTD | PMID:20638727 |
| 2,2,2-tetramine | increases activity | ISO | RGD:69147 | 6480464 | Trientine results in increased activity of CASP9 protein | CTD | PMID:14513838 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:62159 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CASP9 mRNA | CTD | PMID:15667827 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:69147 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CASP9 mRNA | CTD | PMID:23152189 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:62159 | 6480464 | Tetrachlorodibenzodioxin affects the expression of CASP9 mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of CASP9 mRNA | CTD | PMID:22298810 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CASP9 mRNA | CTD | PMID:19520675 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:62159 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CASP9 protein | CTD | PMID:15972635 |
| 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2,4-dinitrotoluene affects the expression of CASP9 mRNA | CTD | PMID:21346803 |
| 2-amino-2-deoxy-D-galactopyranose | multiple interactions | ISO | RGD:62159 | 6480464 | [Galactosamine co-treated with Lipopolysaccharides] results in increased cleavage of and results in increased activity of CASP9 protein; more ... | CTD | PMID:20558151 |
| 2-deoxy-D-glucose | multiple interactions | ISO | RGD:69147 | 6480464 | [Deoxyglucose co-treated with Cisplatin] results in increased activity of CASP9 protein | CTD | PMID:20138251 |
| 3',4',7-trihydroxyisoflavone | multiple interactions | ISO | RGD:69147 | 6480464 | 3',4',7-trihydroxyisoflavone promotes the reaction [Epirubicin results in increased expression of CASP9 mRNA]; more ... | CTD | PMID:22914566 |
| 3',4',7-trihydroxyisoflavone | increases expression | ISO | RGD:69147 | 6480464 | 3',4',7-trihydroxyisoflavone results in increased expression of CASP9 mRNA | CTD | PMID:22914566 |
| 3',4',7-trihydroxyisoflavone | increases activity | ISO | RGD:69147 | 6480464 | 3',4',7-trihydroxyisoflavone results in increased activity of CASP9 protein | CTD | PMID:22914566 |
| 3-aminobenzamide | multiple interactions | EXP | | 6480464 | 3-aminobenzamide inhibits the reaction [Hydrogen Peroxide results in increased cleavage of CASP9 protein] | CTD | PMID:16505238 |
| 3-hydroxybutyric acid | multiple interactions | ISO | RGD:69147 | 6480464 | 3-Hydroxybutyric Acid inhibits the reaction [Rotenone results in increased activity of CASP9 protein] | CTD | PMID:16917840 |
| 3-methyladenine | multiple interactions | ISO | RGD:69147 | 6480464 | 3-methyladenine promotes the reaction [ABT-737 results in increased cleavage of CASP9 protein]; more ... | CTD | PMID:20104024 |
| 3-methyladenine | multiple interactions | EXP | | 6480464 | 3-methyladenine promotes the reaction [Staurosporine results in increased cleavage of CASP9 protein] | CTD | PMID:16497721 |
| 3-methyladenine | multiple interactions | EXP | | 6480464 | 3-methyladenine inhibits the reaction [Aminolevulinic Acid analog results in increased activity of CASP9 protein] | CTD | PMID:20426806 |
| 3-nitropropanoic acid | increases activity | EXP | | 6480464 | 3-nitropropionic acid results in increased activity of CASP9 protein | CTD | PMID:15571979 |
| 4'-epidoxorubicin | multiple interactions | ISO | RGD:69147 | 6480464 | Epirubicin promotes the reaction [3',4',7-trihydroxyisoflavone results in increased activity of CASP9 protein]; more ... | CTD | PMID:22914566 |
| 4'-epidoxorubicin | increases expression | ISO | RGD:69147 | 6480464 | Epirubicin results in increased expression of CASP9 mRNA | CTD | PMID:22914566 |
| 4-hydroperoxycyclophosphamide | increases activity | ISO | RGD:62159 | 6480464 | perfosfamide results in increased activity of CASP9 protein | CTD | PMID:16488414 |
| 4-hydroxynon-2-enal | increases activity | EXP | | 6480464 | 4-hydroxy-2-nonenal results in increased activity of CASP9 protein | CTD | PMID:21187080 |
| 4-hydroxynon-2-enal | multiple interactions | ISO | RGD:62159 | 6480464 | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [4-hydroxy-2-nonenal results in increased activity of CASP9 protein]; more ... | CTD | PMID:16322078 |
| 4-hydroxynon-2-enal | increases activity | ISO | RGD:62159 | 6480464 | 4-hydroxy-2-nonenal results in increased activity of CASP9 protein | CTD | PMID:16322078 PMID:17263905 |
| 4-hydroxynon-2-enal | increases activity | ISO | RGD:62159 | 6480464 | 4-hydroxy-2-nonenal results in increased activity of CASP9 protein | CTD | PMID:17263905 PMID:16322078 |
| 4-hydroxyphenyl retinamide | multiple interactions | ISO | RGD:69147 | 6480464 | [Fenretinide co-treated with TNFSF10 protein] results in increased activity of CASP9 protein | CTD | PMID:17273769 |
| 4-hydroxyphenyl retinamide | multiple interactions | ISO | RGD:69147 | 6480464 | PD 169316 inhibits the reaction [Fenretinide results in increased cleavage of CASP9 protein]; more ... | CTD | PMID:16407847 |
| 4-nonylphenol | increases cleavage | ISO | RGD:62159 | 6480464 | 4-nonylphenol results in increased cleavage of CASP9 protein | CTD | PMID:22056370 |
| 4-vinylcyclohexene dioxide | affects expression | ISO | RGD:62159 | 6480464 | 4-vinyl-1-cyclohexene dioxide affects the expression of CASP9 mRNA | CTD | PMID:20829426 |
| 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide | increases activity | EXP | | 6480464 | AICA ribonucleotide results in increased activity of CASP9 protein | CTD | PMID:16469385 |
| 5-aminolevulinic acid | increases activity | ISO | RGD:69147 | 6480464 | Aminolevulinic Acid analog results in increased activity of CASP9 protein | CTD | PMID:21138480 PMID:17245620 |
| 5-aminolevulinic acid | increases activity | ISO | RGD:69147 | 6480464 | Aminolevulinic Acid analog results in increased activity of CASP9 protein | CTD | PMID:17245620 PMID:21138480 |
| 5-aminolevulinic acid | increases activity | EXP | | 6480464 | Aminolevulinic Acid analog results in increased activity of CASP9 protein | CTD | PMID:20426806 |
| 5-aminolevulinic acid | multiple interactions | EXP | | 6480464 | 3-methyladenine inhibits the reaction [Aminolevulinic Acid analog results in increased activity of CASP9 protein] | CTD | PMID:20426806 |
| 5-aminolevulinic acid | multiple interactions | ISO | RGD:69147 | 6480464 | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [Aminolevulinic Acid analog results in increased activity of CASP9 protein] | CTD | PMID:21138480 |
| 5-aza-2'-deoxycytidine | increases cleavage | ISO | RGD:69147 | 6480464 | decitabine results in increased cleavage of CASP9 protein | CTD | PMID:18636160 |
| 5-aza-2'-deoxycytidine | multiple interactions | ISO | RGD:69147 | 6480464 | [decitabine affects the methylation of CASP9 gene] which affects the expression of CASP9 protein | CTD | PMID:18649362 PMID:18649362 |
| 5-aza-2'-deoxycytidine | multiple interactions | ISO | RGD:69147 | 6480464 | pifithrin inhibits the reaction [[decitabine co-treated with Busulfan] results in increased activity of CASP9 protein] | CTD | PMID:19732952 |
| 5-aza-2'-deoxycytidine | multiple interactions | ISO | RGD:69147 | 6480464 | [decitabine co-treated with TNFSF10 protein] results in increased activity of CASP9 protein | CTD | PMID:18636160 |
| 5-aza-2'-deoxycytidine | multiple interactions | ISO | RGD:69147 | 6480464 | [decitabine affects the methylation of CASP9 gene] which affects the expression of CASP9 protein | CTD | PMID:18649362 |
| 5-fluorouracil | multiple interactions | ISO | RGD:69147 | 6480464 | Fluorouracil promotes the reaction [[Doxorubicin co-treated with Paclitaxel] results in increased activity of CASP9 protein] | CTD | PMID:16168113 |
| 5-fluorouracil | multiple interactions | ISO | RGD:69147 | 6480464 | Fluorouracil promotes the reaction [arsenic trioxide results in decreased expression of CASP9 protein] | CTD | PMID:22963400 |
| 5-fluorouracil | increases activity | ISO | RGD:69147 | 6480464 | Fluorouracil results in increased activity of CASP9 protein | CTD | PMID:10779637 more ... |
| 5-fluorouracil | increases activity | ISO | RGD:69147 | 6480464 | Fluorouracil results in increased activity of CASP9 protein | CTD | PMID:17056233 more ... |
| 5-fluorouracil | increases activity | ISO | RGD:69147 | 6480464 | Fluorouracil results in increased activity of CASP9 protein | CTD | PMID:17056233 more ... |
| 5-fluorouracil | multiple interactions | ISO | RGD:69147 | 6480464 | [Fluorouracil co-treated with aloe emodin] affects the expression of CASP9; more ... | CTD | PMID:19928967 |
| 5-fluorouracil | increases activity | ISO | RGD:69147 | 6480464 | Fluorouracil results in increased activity of CASP9 protein | CTD | PMID:10779637 more ... |
| 5-fluorouracil | increases cleavage | ISO | RGD:69147 | 6480464 | Fluorouracil results in increased cleavage of CASP9 protein | CTD | PMID:19816940 PMID:17498489 |
| 5-fluorouracil | increases activity | ISO | RGD:69147 | 6480464 | Fluorouracil results in increased activity of CASP9 protein | CTD | PMID:16803524 more ... |
| 5-fluorouracil | increases activity | ISO | RGD:69147 | 6480464 | Fluorouracil results in increased activity of CASP9 protein | CTD | PMID:16803524 more ... |
| 5-fluorouracil | multiple interactions | ISO | RGD:69147 | 6480464 | CASP8 affects the reaction [Fluorouracil promotes the reaction [andrographolide results in increased activity of CASP9 protein]] | CTD | PMID:19097688 |
| 5-fluorouracil | multiple interactions | ISO | RGD:69147 | 6480464 | [Fluorouracil co-treated with Cisplatin] results in increased activity of CASP9 protein; more ... | CTD | PMID:16803524 |
| 5-fluorouracil | multiple interactions | ISO | RGD:69147 | 6480464 | [Docosahexaenoic Acids co-treated with Fluorouracil] results in decreased expression of CASP9 mRNA | CTD | PMID:19015929 |
| 5-fluorouracil | multiple interactions | ISO | RGD:69147 | 6480464 | FAS protein affects the reaction [Fluorouracil results in increased activity of CASP9 protein] | CTD | PMID:17056233 |
| 5-fluorouracil | multiple interactions | ISO | RGD:69147 | 6480464 | RNF34 protein inhibits the reaction [Fluorouracil results in increased activity of CASP9 protein] | CTD | PMID:16407826 |
| 5-fluorouracil | multiple interactions | ISO | RGD:69147 | 6480464 | PTGS2 protein inhibits the reaction [Fluorouracil results in increased activity of CASP9 protein] | CTD | PMID:12414664 |
| 5-fluorouracil | increases expression | ISO | RGD:69147 | 6480464 | Fluorouracil results in increased expression of CASP9 protein | CTD | PMID:16803524 |
| 5-fluorouracil | multiple interactions | ISO | RGD:69147 | 6480464 | IFNA1 protein promotes the reaction [Fluorouracil results in increased activity of CASP9 protein] | CTD | PMID:17016659 |
| 5-fluorouracil | increases cleavage | ISO | RGD:69147 | 6480464 | Fluorouracil results in increased cleavage of CASP9 protein | CTD | PMID:17498489 PMID:19816940 |
| 5-fluorouracil | multiple interactions | ISO | RGD:69147 | 6480464 | Fluorouracil results in increased cleavage of and results in increased activity of CASP9 protein; more ... | CTD | PMID:15546879 |
| 5-fluorouracil | increases activity | ISO | RGD:69147 | 6480464 | Fluorouracil results in increased activity of CASP9 protein | CTD | PMID:16407826 more ... |
| 8-bromo-3',5'-cyclic AMP | increases expression | ISO | RGD:69147 | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CASP9 mRNA | CTD | PMID:22079614 |
| 9'-cis-neoxanthin | multiple interactions | ISO | RGD:69147 | 6480464 | neoxanthin results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:17186379 |
| acetylsalicylic acid | multiple interactions | ISO | RGD:69147 | 6480464 | Aspirin inhibits the reaction [Hydrogen Peroxide results in increased activity of CASP9 protein] | CTD | PMID:14753751 |
| acetylsalicylic acid | multiple interactions | ISO | RGD:69147 | 6480464 | Aspirin inhibits the reaction [Deoxycholic Acid results in increased activity of CASP9 protein] | CTD | PMID:17644113 |
| acetylsalicylic acid | increases activity | ISO | RGD:62159 | 6480464 | Aspirin results in increased activity of CASP9 protein | CTD | PMID:16880202 |
| acetylsalicylic acid | multiple interactions | ISO | RGD:69147 | 6480464 | Aspirin results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:15481331 |
| acetylsalicylic acid | multiple interactions | ISO | RGD:69147 | 6480464 | [TNFSF10 protein co-treated with Aspirin] results in increased cleavage of and results in increased activity of CASP9 protein; more ... | CTD | PMID:16199534 |
| acetylsalicylic acid | increases activity | ISO | RGD:69147 | 6480464 | Aspirin results in increased activity of CASP9 protein | CTD | PMID:11034327 |
| acrolein | increases activity | ISO | RGD:69147 | 6480464 | Acrolein results in increased activity of CASP9 protein | CTD | PMID:19596284 |
| acrolein | decreases activity | ISO | RGD:62159 | 6480464 | Acrolein results in decreased activity of CASP9 protein | CTD | PMID:11803030 |
| actinomycin D | multiple interactions | ISO | RGD:69147 | 6480464 | [Dactinomycin co-treated with TNFSF10 protein] results in increased activity of CASP9 protein | CTD | PMID:17707539 |
| adenosine | increases activity | ISO | RGD:69147 | 6480464 | Adenosine results in increased activity of CASP9 protein | CTD | PMID:11570579 |
| adenosine | increases activity | EXP | | 6480464 | Adenosine results in increased activity of CASP9 protein | CTD | PMID:16469385 |
| adenosine | multiple interactions | ISO | RGD:69147 | 6480464 | Thymidine inhibits the reaction [Adenosine results in increased activity of CASP9 protein] | CTD | PMID:11570579 |
| aflatoxin B1 | increases cleavage | ISO | RGD:69147 | 6480464 | Aflatoxin B1 results in increased cleavage of CASP9 protein | CTD | PMID:22743290 |
| alantolactone | increases cleavage | ISO | RGD:69147 | 6480464 | alantolactone results in increased cleavage of CASP9 protein | CTD | PMID:22721982 |
| alendronic acid | multiple interactions | ISO | RGD:69147 | 6480464 | TNFSF11 inhibits the reaction [Alendronate results in increased expression of CASP9 protein] | CTD | PMID:19405951 |
| all-trans-acitretin | increases activity | ISO | RGD:69147 | 6480464 | Acitretin results in increased activity of CASP9 protein | CTD | PMID:18624760 |
| all-trans-neoxanthin | multiple interactions | ISO | RGD:69147 | 6480464 | neoxanthin results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:17186379 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:69147 | 6480464 | CRABP2 protein promotes the reaction [Tretinoin results in increased cleavage of and results in increased activity of CASP9 protein]; more ... | CTD | PMID:16166294 |
| all-trans-retinoic acid | decreases expression | ISO | RGD:62159 | 6480464 | Tretinoin results in decreased expression of CASP9 mRNA | CTD | PMID:22498432 |
| all-trans-retinoic acid | increases expression | ISO | RGD:69147 | 6480464 | Tretinoin results in increased expression of CASP9 mRNA | CTD | PMID:16166294 PMID:15498508 |
| all-trans-retinoic acid | increases expression | ISO | RGD:69147 | 6480464 | Tretinoin results in increased expression of CASP9 mRNA | CTD | PMID:15498508 PMID:16166294 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:69147 | 6480464 | Tretinoin results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:16166294 PMID:17387344 |
| all-trans-retinoic acid | increases expression | ISO | RGD:62159 | 6480464 | Tretinoin results in increased expression of CASP9 protein | CTD | PMID:16764683 |
| all-trans-retinoic acid | increases activity | ISO | RGD:62159 | 6480464 | Tretinoin results in increased activity of CASP9 protein | CTD | PMID:16291826 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:62159 | 6480464 | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [Tretinoin results in increased activity of CASP9 protein] | CTD | PMID:16291826 |
| all-trans-retinoic acid | increases expression | ISO | RGD:69147 | 6480464 | Tretinoin results in increased expression of CASP9 mRNA | CTD | PMID:16166294 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:69147 | 6480464 | [Tretinoin co-treated with Paclitaxel] results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:17701358 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:69147 | 6480464 | Tretinoin results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:17387344 PMID:16166294 |
| all-trans-retinoic acid | increases activity | ISO | RGD:69147 | 6480464 | Tretinoin results in increased activity of CASP9 protein | CTD | PMID:16568081 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:69147 | 6480464 | [IFNB1 protein co-treated with Tretinoin] results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:16826196 |
| alternariol | increases activity | ISO | RGD:69147 | 6480464 | alternariol results in increased activity of CASP9 protein | CTD | PMID:22542754 |
| aluminium trichloride | increases expression | EXP | | 6480464 | aluminum chloride results in increased expression of CASP9 mRNA | CTD | PMID:23065425 |
| amiloride | multiple interactions | ISO | RGD:69147 | 6480464 | Amiloride promotes the reaction [TNFSF10 protein results in increased cleavage of and results in increased activity of CASP9 protein] | CTD | PMID:16059913 |
| aminoguanidine | multiple interactions | ISO | RGD:62159 | 6480464 | pimagedine inhibits the reaction [Cardiotoxins results in increased cleavage of CASP9 protein] | CTD | PMID:17786558 |
| amiodarone | increases expression | ISO | RGD:69147 | 6480464 | Amiodarone results in increased expression of CASP9 mRNA | CTD | PMID:19774075 |
| amiodarone | multiple interactions | ISO | RGD:62159 | 6480464 | [Amiodarone co-treated with TNF protein] results in increased activity of CASP9 protein | CTD | PMID:23042730 |
| amiodarone | multiple interactions | ISO | RGD:69147 | 6480464 | [TNFSF10 co-treated with Amiodarone] results in increased cleavage of CASP9 protein | CTD | PMID:21292685 |
| ammonium chloride | multiple interactions | EXP | | 6480464 | (1,2,5,6-tetrahydropyridin-4-yl)methylphosphinic acid inhibits the reaction [4-aminocrotonic acid inhibits the reaction [Ammonium Chloride results in increased activity of CASP9 protein]] | CTD | PMID:14535961 |
| ammonium chloride | increases activity | EXP | | 6480464 | Ammonium Chloride results in increased activity of CASP9 protein | CTD | PMID:14535961 PMID:18722528 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of CASP9 mRNA | CTD | PMID:16483693 |
| ammonium chloride | increases expression | EXP | | 6480464 | Ammonium Chloride results in increased expression of CASP9 protein | CTD | PMID:16483693 |
| ammonium chloride | increases activity | EXP | | 6480464 | Ammonium Chloride results in increased activity of CASP9 protein | CTD | PMID:18722528 PMID:14535961 |
| amosite asbestos | multiple interactions | EXP | | 6480464 | pifithrin inhibits the reaction [Asbestos, Amosite results in increased activity of CASP9 protein] | CTD | PMID:16357363 |
| amosite asbestos | increases activity | EXP | | 6480464 | Asbestos, Amosite results in increased activity of CASP9 protein | CTD | PMID:16357363 |
| amphetamine | increases activity | EXP | | 6480464 | Amphetamine results in increased activity of CASP9 protein | CTD | PMID:16638611 |
| andrographolide | increases activity | ISO | RGD:69147 | 6480464 | andrographolide results in increased activity of CASP9 protein | CTD | PMID:19097688 |
| andrographolide | multiple interactions | EXP | | 6480464 | andrographolide promotes the reaction [Penicillamine inhibits the reaction [Copper Sulfate results in increased activity of CASP9 protein]]; more ... | CTD | PMID:20946909 |
| andrographolide | multiple interactions | ISO | RGD:69147 | 6480464 | Fluorouracil promotes the reaction [andrographolide results in increased activity of CASP9 protein]; more ... | CTD | PMID:19097688 |
| apigenin | increases cleavage | ISO | RGD:69147 | 6480464 | Apigenin results in increased cleavage of CASP9 protein | CTD | PMID:15486995 PMID:19397994 |
| apigenin | increases cleavage | ISO | RGD:69147 | 6480464 | Apigenin results in increased cleavage of CASP9 protein | CTD | PMID:19397994 PMID:15486995 |
| arachidonic acid | increases activity | ISO | RGD:69147 | 6480464 | Arachidonic Acid results in increased activity of CASP9 protein | CTD | PMID:19540902 |
| arachidonic acid | increases activity | ISO | RGD:69147 | 6480464 | Arachidonic Acid results in increased activity of CASP9 protein | CTD | PMID:19540902 PMID:19720122 |
| Aroclor 1254 | multiple interactions | EXP | | 6480464 | Quercetin inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in increased expression of CASP9 mRNA] | CTD | PMID:23281070 |
| Aroclor 1254 | increases expression | EXP | | 6480464 | Chlorodiphenyl (54% Chlorine) results in increased expression of CASP9 mRNA | CTD | PMID:23281070 |
| arsenic atom | increases expression | ISO | RGD:69147 | 6480464 | Arsenic results in increased expression of CASP9 mRNA | CTD | PMID:11134558 |
| arsenite(3-) | affects expression | ISO | RGD:69147 | 6480464 | arsenite affects the expression of CASP9 protein | CTD | PMID:20083129 |
| arsenite(3-) | multiple interactions | ISO | RGD:69147 | 6480464 | [arsenite results in decreased activity of PARP1 protein] which results in decreased cleavage of and results in decreased activity of CASP9 protein; more ... | CTD | PMID:22387748 |
| arsenite(3-) | increases cleavage | ISO | RGD:69147 | 6480464 | arsenite results in increased cleavage of CASP9 protein | CTD | PMID:17553788 |
| asbestos | increases activity | EXP | | 6480464 | Asbestos results in increased activity of CASP9 protein | CTD | PMID:15618436 |
| asbestos | multiple interactions | EXP | | 6480464 | FGF10 protein inhibits the reaction [Asbestos results in increased activity of CASP9 protein]; more ... | CTD | PMID:15618436 |
| atrazine | multiple interactions | ISO | RGD:69147 | 6480464 | kolaviron inhibits the reaction [Atrazine results in increased expression of CASP9 mRNA] | CTD | PMID:21333729 |
| atrazine | multiple interactions | EXP | | 6480464 | kolaviron inhibits the reaction [Atrazine affects the expression of CASP9] | CTD | PMID:21726175 |
| atrazine | affects expression | EXP | | 6480464 | Atrazine affects the expression of CASP9 | CTD | PMID:21726175 |
| atrazine | increases expression | ISO | RGD:69147 | 6480464 | Atrazine results in increased expression of CASP9 mRNA | CTD | PMID:21333729 |
| auranofin | multiple interactions | ISO | RGD:69147 | 6480464 | Auranofin results in decreased expression of and results in increased cleavage of CASP9 protein | CTD | PMID:20542334 |
| azadirachtin A | increases expression | ISO | RGD:69147 | 6480464 | azadirachtin results in increased expression of CASP9 mRNA; more ... | CTD | PMID:20429769 |
| benzene | increases expression | EXP | | 6480464 | Benzene results in increased expression of CASP9 protein | CTD | PMID:17171516 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:69147 | 6480464 | Nitrogen Oxides inhibits the reaction [Benzo(a)pyrene results in increased cleavage of CASP9 protein] | CTD | PMID:16041517 |
| benzo[a]pyrene | increases expression | ISO | RGD:69147 | 6480464 | Benzo(a)pyrene results in increased expression of CASP9 mRNA | CTD | PMID:21393351 |
| benzo[a]pyrene | multiple interactions | EXP | | 6480464 | Glycyrrhizic Acid inhibits the reaction [Benzo(a)pyrene results in increased activity of CASP9 protein] | CTD | PMID:22051199 |
| benzo[a]pyrene | increases activity | EXP | | 6480464 | Benzo(a)pyrene results in increased activity of CASP9 protein | CTD | PMID:22051199 |
| benzo[a]pyrene | increases cleavage | ISO | RGD:69147 | 6480464 | Benzo(a)pyrene results in increased cleavage of CASP9 protein | CTD | PMID:16041517 |
| berberine | increases cleavage | ISO | RGD:69147 | 6480464 | Berberine results in increased cleavage of CASP9 protein | CTD | PMID:16505103 |
| bis(2-chloroethyl) sulfide | multiple interactions | ISO | RGD:69147 | 6480464 | CALM1 protein promotes the reaction [Mustard Gas results in increased cleavage of and results in increased activity of CASP9 protein] | CTD | PMID:16935404 |
| bis(2-chloroethyl) sulfide | increases cleavage | ISO | RGD:69147 | 6480464 | Mustard Gas results in increased cleavage of CASP9 protein | CTD | PMID:20435105 |
| bis(2-chloroethyl) sulfide | increases cleavage | EXP | | 6480464 | Mustard Gas results in increased cleavage of CASP9 protein | CTD | PMID:20659490 |
| bis(2-chloroethyl) sulfide | increases activity | ISO | RGD:69147 | 6480464 | Mustard Gas results in increased activity of CASP9 protein | CTD | PMID:12482751 more ... |
| bis(2-chloroethyl) sulfide | multiple interactions | ISO | RGD:69147 | 6480464 | BRCA2 protein inhibits the reaction [Mustard Gas results in increased cleavage of CASP9 protein] | CTD | PMID:20435105 |
| bis(2-chloroethyl) sulfide | increases activity | ISO | RGD:69147 | 6480464 | Mustard Gas results in increased activity of CASP9 protein | CTD | PMID:20226831 more ... |
| bis(2-chloroethyl) sulfide | increases activity | ISO | RGD:69147 | 6480464 | Mustard Gas results in increased activity of CASP9 protein | CTD | PMID:16738803 more ... |
| bis(2-chloroethyl) sulfide | multiple interactions | ISO | RGD:69147 | 6480464 | benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [Mustard Gas results in increased activity of CASP9 protein]; more ... | CTD | PMID:20226831 |
| bis(2-chloroethyl) sulfide | multiple interactions | ISO | RGD:69147 | 6480464 | Mustard Gas results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:18161513 PMID:16935404 |
| bis(2-chloroethyl) sulfide | increases activity | ISO | RGD:69147 | 6480464 | Mustard Gas results in increased activity of CASP9 protein | CTD | PMID:16738803 PMID:12482751 |
| bis(2-chloroethyl) sulfide | multiple interactions | ISO | RGD:69147 | 6480464 | Mustard Gas results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:16935404 PMID:18161513 |
| bis(2-chloroethyl) sulfide | increases activity | ISO | RGD:69147 | 6480464 | Mustard Gas results in increased activity of CASP9 protein | CTD | PMID:12482751 PMID:16738803 |
| bis(2-ethylhexyl) phthalate | increases activity | ISO | RGD:69147 | 6480464 | Diethylhexyl Phthalate results in increased activity of CASP9 protein | CTD | PMID:22155658 |
| bisphenol A | increases expression | ISO | RGD:69147 | 6480464 | bisphenol A results in increased expression of CASP9 protein | CTD | PMID:21277958 |
| bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of CASP9 protein | CTD | PMID:17322771 |
| bleomycin A2 | multiple interactions | EXP | | 6480464 | Bleomycin results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:15371238 |
| bleomycin A2 | increases activity | ISO | RGD:62159 | 6480464 | Bleomycin results in increased activity of CASP9 protein | CTD | PMID:22687607 |
| bupivacaine | decreases expression | ISO | RGD:69147 | 6480464 | Bupivacaine results in decreased expression of CASP9 protein | CTD | PMID:20194319 |
| bupropion | increases activity | ISO | RGD:69147 | 6480464 | Bupropion results in increased activity of CASP9 protein | CTD | PMID:21354251 |
| busulfan | multiple interactions | ISO | RGD:69147 | 6480464 | [clofarabine co-treated with fludarabine co-treated with Busulfan] results in increased cleavage of CASP9 protein | CTD | PMID:20933509 |
| busulfan | multiple interactions | ISO | RGD:69147 | 6480464 | pifithrin inhibits the reaction [[decitabine co-treated with Busulfan] results in increased activity of CASP9 protein] | CTD | PMID:19732952 |
| butan-1-ol | multiple interactions | EXP | | 6480464 | Y 27632 inhibits the reaction [1-Butanol results in increased activity of and results in increased cleavage of CASP9 protein]; more ... | CTD | PMID:22564901 |
| cadmium atom | multiple interactions | ISO | RGD:69147 | 6480464 | Cadmium results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:19442655 |
| cadmium atom | increases activity | EXP | | 6480464 | Cadmium results in increased activity of CASP9 protein | CTD | PMID:14977363 more ... |
| cadmium atom | increases activity | EXP | | 6480464 | Cadmium results in increased activity of CASP9 protein | CTD | PMID:16478757 more ... |
| cadmium atom | increases activity | ISO | RGD:62159 | 6480464 | Cadmium results in increased activity of CASP9 protein | CTD | PMID:19182378 |
| cadmium atom | multiple interactions | ISO | RGD:62159 | 6480464 | hwanggunchungyitang inhibits the reaction [Cadmium results in increased activity of CASP9 protein] | CTD | PMID:19182378 |
| cadmium atom | increases activity | EXP | | 6480464 | Cadmium results in increased activity of CASP9 protein | CTD | PMID:16478757 PMID:16809017 |
| cadmium atom | increases activity | EXP | | 6480464 | Cadmium results in increased activity of CASP9 protein | CTD | PMID:16809017 PMID:16478757 |
| cadmium atom | multiple interactions | EXP | | 6480464 | Cadmium inhibits the reaction [Camptothecin results in increased activity of CASP9 protein]; more ... | CTD | PMID:16263807 |
| cadmium dichloride | multiple interactions | ISO | RGD:62159 | 6480464 | arjunolic acid inhibits the reaction [Cadmium Chloride results in increased activity of CASP9 protein] | CTD | PMID:21420465 |
| cadmium dichloride | increases activity | EXP | | 6480464 | Cadmium Chloride results in increased activity of CASP9 protein | CTD | PMID:16478757 more ... |
| cadmium dichloride | increases activity | EXP | | 6480464 | Cadmium Chloride results in increased activity of CASP9 protein | CTD | PMID:16478757 more ... |
| cadmium dichloride | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased activity of CASP9 protein]; more ... | CTD | PMID:18629305 |
| cadmium dichloride | increases activity | ISO | RGD:62159 | 6480464 | Cadmium Chloride results in increased activity of CASP9 protein | CTD | PMID:21420465 PMID:18850067 |
| cadmium dichloride | multiple interactions | ISO | RGD:62159 | 6480464 | 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Cadmium Chloride results in increased activity of CASP9 protein] | CTD | PMID:18850067 |
| cadmium dichloride | increases activity | EXP | | 6480464 | Cadmium Chloride results in increased activity of CASP9 protein | CTD | PMID:16478757 more ... |
| cadmium dichloride | increases activity | ISO | RGD:62159 | 6480464 | Cadmium Chloride results in increased activity of CASP9 protein | CTD | PMID:18850067 PMID:21420465 |
| cadmium dichloride | increases activity | ISO | RGD:69147 | 6480464 | Cadmium Chloride results in increased activity of CASP9 protein | CTD | PMID:16264267 |
| cadmium dichloride | increases activity | EXP | | 6480464 | Cadmium Chloride results in increased activity of CASP9 protein | CTD | PMID:16478757 PMID:16809017 |
| cadmium dichloride | increases activity | EXP | | 6480464 | Cadmium Chloride results in increased activity of CASP9 protein | CTD | PMID:16809017 PMID:16478757 |
| cadmium dichloride | multiple interactions | EXP | | 6480464 | Cadmium Chloride inhibits the reaction [Camptothecin results in increased activity of CASP9 protein]; more ... | CTD | PMID:16263807 |
| cadmium dichloride | increases activity | ISO | RGD:62159 | 6480464 | Cadmium Chloride results in increased activity of CASP9 protein | CTD | PMID:21420465 |
| caffeine | multiple interactions | ISO | RGD:69147 | 6480464 | Caffeine results in increased cleavage of and results in increased expression of CASP9 protein | CTD | PMID:16522534 |
| caffeine | multiple interactions | ISO | RGD:62159 | 6480464 | Caffeine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of CASP9 mRNA]; more ... | CTD | PMID:20230807 |
| caffeine | multiple interactions | ISO | RGD:69147 | 6480464 | Caffeine inhibits the reaction [silybin results in increased cleavage of and results in increased activity of CASP9 protein] | CTD | PMID:16777994 |
| calciol | decreases expression | ISO | RGD:69147 | 6480464 | Cholecalciferol results in decreased expression of CASP9 protein | CTD | PMID:18628207 |
| calcitriol | multiple interactions | ISO | RGD:69147 | 6480464 | [Calcitriol co-treated with gemcitabine] results in increased expression of CASP9 protein | CTD | PMID:20699664 |
| camptothecin | multiple interactions | ISO | RGD:69147 | 6480464 | [Camptothecin co-treated with FAS protein] results in increased activity of CASP9 protein | CTD | PMID:15958570 |
| camptothecin | multiple interactions | EXP | | 6480464 | Naphthoquinones analog inhibits the reaction [Camptothecin results in increased activity of CASP9 protein] | CTD | PMID:19497415 |
| camptothecin | increases activity | EXP | | 6480464 | Camptothecin results in increased activity of CASP9 protein | CTD | PMID:16263807 |
| camptothecin | multiple interactions | EXP | | 6480464 | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [Camptothecin results in increased cleavage of CASP9 protein]; more ... | CTD | PMID:16263807 |
| camptothecin | increases cleavage | ISO | RGD:69147 | 6480464 | Camptothecin results in increased cleavage of CASP9 protein | CTD | PMID:10896673 |
| camptothecin | multiple interactions | ISO | RGD:69147 | 6480464 | [Camptothecin co-treated with FAS protein] results in increased cleavage of CASP9 protein | CTD | PMID:19633536 |
| capsaicin | multiple interactions | ISO | RGD:69147 | 6480464 | [Capsaicin co-treated with TNFSF10 protein] results in increased cleavage of CASP9 protein | CTD | PMID:19939880 |
| capsaicin | increases activity | ISO | RGD:69147 | 6480464 | Capsaicin results in increased activity of CASP9 protein | CTD | PMID:19502594 more ... |
| capsaicin | increases activity | ISO | RGD:69147 | 6480464 | Capsaicin results in increased activity of CASP9 protein | CTD | PMID:19502594 more ... |
| capsaicin | increases activity | ISO | RGD:69147 | 6480464 | Capsaicin results in increased activity of CASP9 protein | CTD | PMID:19855437 more ... |
| capsaicin | increases activity | ISO | RGD:69147 | 6480464 | Capsaicin results in increased activity of CASP9 protein | CTD | PMID:19502594 more ... |
| capsaicin | increases expression | EXP | | 6480464 | Capsaicin results in increased expression of CASP9 protein | CTD | PMID:16125681 |
| capsaicin | affects expression | EXP | | 6480464 | Capsaicin affects the expression of CASP9 protein | CTD | PMID:16477149 |
| capsaicin | multiple interactions | ISO | RGD:69147 | 6480464 | EUK-134 inhibits the reaction [Capsaicin results in increased cleavage of CASP9 protein]; more ... | CTD | PMID:21647434 |
| capsaicin | increases expression | ISO | RGD:69147 | 6480464 | Capsaicin results in increased expression of CASP9 mRNA | CTD | PMID:19502594 |
| capsaicin | increases activity | ISO | RGD:69147 | 6480464 | Capsaicin results in increased activity of CASP9 protein | CTD | PMID:19502594 |
| capsaicin | increases cleavage | ISO | RGD:69147 | 6480464 | Capsaicin results in increased cleavage of CASP9 protein | CTD | PMID:21647434 |
| capsaicin | increases activity | ISO | RGD:69147 | 6480464 | Capsaicin results in increased activity of CASP9 protein | CTD | PMID:19699254 more ... |
| capsaicin | multiple interactions | ISO | RGD:69147 | 6480464 | Capsaicin promotes the reaction [TNFSF10 results in increased activity of CASP9 protein] | CTD | PMID:22200406 |
| carboplatin | decreases expression | ISO | RGD:69147 | 6480464 | Carboplatin results in decreased expression of CASP9 mRNA | CTD | PMID:17404015 PMID:15576332 |
| carboplatin | decreases expression | ISO | RGD:69147 | 6480464 | Carboplatin results in decreased expression of CASP9 mRNA | CTD | PMID:15576332 PMID:17404015 |
| carboplatin | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [Carboplatin results in increased expression of CASP9 protein]; more ... | CTD | PMID:18483861 |
| carboplatin | increases expression | ISO | RGD:62159 | 6480464 | Carboplatin results in increased expression of CASP9 protein | CTD | PMID:18483861 |
| carboplatin | increases activity | ISO | RGD:69147 | 6480464 | Carboplatin results in increased activity of CASP9 protein | CTD | PMID:15996812 |
| celastrol | increases cleavage | ISO | RGD:69147 | 6480464 | tripterine results in increased cleavage of CASP9 protein | CTD | PMID:21466843 |
| celecoxib | increases activity | ISO | RGD:62159 | 6480464 | celecoxib results in increased activity of CASP9 protein | CTD | PMID:17761345 PMID:17201140 |
| celecoxib | increases cleavage | ISO | RGD:69147 | 6480464 | celecoxib results in increased cleavage of CASP9 protein | CTD | PMID:19665451 more ... |
| celecoxib | increases cleavage | ISO | RGD:69147 | 6480464 | celecoxib results in increased cleavage of CASP9 protein | CTD | PMID:17612393 more ... |
| celecoxib | multiple interactions | ISO | RGD:69147 | 6480464 | celecoxib results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:15572759 PMID:15197583 |
| celecoxib | increases activity | ISO | RGD:62159 | 6480464 | celecoxib results in increased activity of CASP9 protein | CTD | PMID:17201140 PMID:17761345 |
| celecoxib | multiple interactions | ISO | RGD:69147 | 6480464 | FADD mutant form inhibits the reaction [celecoxib results in increased cleavage of and results in increased activity of CASP9 protein]; more ... | CTD | PMID:15572759 |
| celecoxib | increases cleavage | ISO | RGD:69147 | 6480464 | celecoxib results in increased cleavage of CASP9 protein | CTD | PMID:20104024 more ... |
| celecoxib | multiple interactions | ISO | RGD:69147 | 6480464 | celecoxib results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:15197583 PMID:15572759 |
| celecoxib | multiple interactions | ISO | RGD:69147 | 6480464 | celecoxib analog results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:15499625 |
| celecoxib | increases activity | ISO | RGD:69147 | 6480464 | celecoxib results in increased activity of CASP9 protein | CTD | PMID:12824303 |
| celecoxib | multiple interactions | ISO | RGD:69147 | 6480464 | celecoxib promotes the reaction [docetaxel results in increased cleavage of and results in increased activity of CASP9 protein]; more ... | CTD | PMID:15688368 |
| celecoxib | multiple interactions | ISO | RGD:69147 | 6480464 | [atorvastatin co-treated with celecoxib] results in increased cleavage of CASP9 protein | CTD | PMID:18172863 |
| celecoxib | multiple interactions | ISO | RGD:69147 | 6480464 | 3-methyladenine promotes the reaction [ABT-737 promotes the reaction [celecoxib results in increased cleavage of CASP9 protein]]; more ... | CTD | PMID:20104024 |
| cerulenin | increases activity | ISO | RGD:62159 | 6480464 | Cerulenin results in increased activity of CASP9 protein | CTD | PMID:20805790 |
| ceruletide | multiple interactions | EXP | | 6480464 | Caerulein results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:16339139 |
| cetrorelix | increases activity | ISO | RGD:62159 | 6480464 | cetrorelix results in increased activity of CASP9 protein | CTD | PMID:17268770 |
| cetrorelix | increases activity | EXP | | 6480464 | cetrorelix results in increased activity of CASP9 protein | CTD | PMID:17268770 |
| chalcone | increases cleavage | ISO | RGD:69147 | 6480464 | Chalcone results in increased cleavage of CASP9 protein | CTD | PMID:20620131 |
| chalcone | multiple interactions | ISO | RGD:69147 | 6480464 | MYC protein affects the susceptibility to [Chalcone results in increased cleavage of CASP9 protein] | CTD | PMID:20620131 |
| chenodeoxycholic acid | multiple interactions | ISO | RGD:69147 | 6480464 | [Chenodeoxycholic Acid co-treated with tauroursodeoxycholic acid] results in increased activity of CASP9 protein | CTD | PMID:14976352 |
| chenodeoxycholic acid | increases activity | ISO | RGD:69147 | 6480464 | Chenodeoxycholic Acid results in increased activity of CASP9 protein | CTD | PMID:14976352 |
| chloroacetic acid | increases cleavage | ISO | RGD:62159 | 6480464 | chloroacetic acid results in increased cleavage of CASP9 protein | CTD | PMID:23103613 |
| chlorpyrifos | affects expression | EXP | | 6480464 | Chlorpyrifos affects the expression of CASP9 mRNA | CTD | PMID:17452286 |
| chlorpyrifos | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [Chlorpyrifos results in increased activity of CASP9 protein] | CTD | PMID:22714038 |
| chlorpyrifos | increases activity | EXP | | 6480464 | Chlorpyrifos results in increased activity of CASP9 protein | CTD | PMID:22714038 |
| cholesterol | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [Cholesterol analog results in increased expression of CASP9 mRNA]; more ... | CTD | PMID:19477266 |
| cholesterol | increases expression | EXP | | 6480464 | Cholesterol analog results in increased expression of CASP9 mRNA | CTD | PMID:19477266 |
| cholesterol | increases activity | EXP | | 6480464 | Cholesterol analog results in increased activity of CASP9 protein | CTD | PMID:19477266 |
| chromium(6+) | multiple interactions | ISO | RGD:62159 | 6480464 | [Arsenates co-treated with chromium hexavalent ion] results in increased activity of CASP9 protein | CTD | PMID:19895865 |
| chrysazin | multiple interactions | ISO | RGD:69147 | 6480464 | danthron results in increased activity of and results in increased expression of CASP9 protein; more ... | CTD | PMID:21126053 |
| chrysazin | increases expression | ISO | RGD:69147 | 6480464 | danthron results in increased expression of CASP9 mRNA | CTD | PMID:21126053 |
| ciglitazone | multiple interactions | ISO | RGD:69147 | 6480464 | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [[Niflumic Acid co-treated with ciglitazone] results in increased cleavage of CASP9 protein]; more ... | CTD | PMID:21067863 |
| cimetidine | increases activity | ISO | RGD:69147 | 6480464 | Cimetidine results in increased activity of CASP9 protein | CTD | PMID:17273750 PMID:20127008 |
| cimetidine | increases activity | ISO | RGD:69147 | 6480464 | Cimetidine results in increased activity of CASP9 protein | CTD | PMID:20127008 PMID:17273750 |
| ciprofloxacin | increases activity | ISO | RGD:69147 | 6480464 | Ciprofloxacin results in increased activity of CASP9 protein | CTD | PMID:11875713 |
| cisplatin | multiple interactions | ISO | RGD:69147 | 6480464 | Acetylcysteine inhibits the reaction [[Cisplatin co-treated with FASLG protein] results in increased activity of CASP9 protein]; more ... | CTD | PMID:17574045 |
| cisplatin | multiple interactions | ISO | RGD:69147 | 6480464 | ABCB1 protein inhibits the reaction [Cisplatin results in increased activity of CASP9 protein] | CTD | PMID:22269388 |
| cisplatin | increases activity | ISO | RGD:62159 | 6480464 | Cisplatin results in increased activity of CASP9 protein | CTD | PMID:21526214 PMID:22269388 |
| cisplatin | multiple interactions | ISO | RGD:62159 | 6480464 | ABCB1 protein inhibits the reaction [Cisplatin results in increased activity of CASP9 protein] | CTD | PMID:22269388 |
| cisplatin | increases activity | ISO | RGD:69147 | 6480464 | Cisplatin results in increased activity of CASP9 protein | CTD | PMID:12565868 more ... |
| cisplatin | increases cleavage | ISO | RGD:69147 | 6480464 | Cisplatin results in increased cleavage of CASP9 protein | CTD | PMID:15496615 more ... |
| cisplatin | increases cleavage | ISO | RGD:69147 | 6480464 | Cisplatin results in increased cleavage of CASP9 protein | CTD | PMID:20145152 more ... |
| cisplatin | increases activity | ISO | RGD:69147 | 6480464 | Cisplatin results in increased activity of CASP9 protein | CTD | PMID:21271225 more ... |
| cisplatin | increases cleavage | ISO | RGD:69147 | 6480464 | Cisplatin results in increased cleavage of CASP9 protein | CTD | PMID:15496615 more ... |
| cisplatin | increases activity | ISO | RGD:69147 | 6480464 | Cisplatin results in increased activity of CASP9 protein | CTD | PMID:21420390 more ... |
| cisplatin | multiple interactions | ISO | RGD:69147 | 6480464 | MIR630 mRNA inhibits the reaction [Cisplatin results in increased cleavage of CASP9 protein] | CTD | PMID:20145152 |
| cisplatin | increases cleavage | ISO | RGD:69147 | 6480464 | Cisplatin results in increased cleavage of CASP9 protein | CTD | PMID:21324178 more ... |
| cisplatin | increases activity | ISO | RGD:69147 | 6480464 | Cisplatin results in increased activity of CASP9 protein | CTD | PMID:16803524 more ... |
| cisplatin | increases activity | ISO | RGD:69147 | 6480464 | Cisplatin results in increased activity of CASP9 protein | CTD | PMID:21420390 more ... |
| cisplatin | increases cleavage | ISO | RGD:69147 | 6480464 | Cisplatin results in increased cleavage of CASP9 protein | CTD | PMID:18058806 more ... |
| cisplatin | increases cleavage | ISO | RGD:69147 | 6480464 | Cisplatin results in increased cleavage of CASP9 protein | CTD | PMID:18058806 more ... |
| cisplatin | increases activity | ISO | RGD:69147 | 6480464 | Cisplatin results in increased activity of CASP9 protein | CTD | PMID:16009487 more ... |
| cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of CASP9 protein | CTD | PMID:21525749 |
| cisplatin | multiple interactions | ISO | RGD:62159 | 6480464 | rosemarinic acid inhibits the reaction [Cisplatin results in increased activity of CASP9 protein] | CTD | PMID:21526214 |
| cisplatin | increases cleavage | ISO | RGD:62159 | 6480464 | Cisplatin results in increased cleavage of CASP9 protein | CTD | PMID:21616140 |
| cisplatin | increases activity | ISO | RGD:62159 | 6480464 | Cisplatin results in increased activity of CASP9 protein | CTD | PMID:21526214 |
| cisplatin | multiple interactions | ISO | RGD:69147 | 6480464 | TYMP inhibits the reaction [Cisplatin results in increased activity of CASP9 protein] | CTD | PMID:14727531 |
| cisplatin | multiple interactions | ISO | RGD:62159 | 6480464 | Acetylcysteine inhibits the reaction [Cisplatin results in increased cleavage of CASP9 protein]; more ... | CTD | PMID:21616140 |
| cisplatin | multiple interactions | ISO | RGD:69147 | 6480464 | TYMP protein inhibits the reaction [Cisplatin results in increased activity of CASP9 protein] | CTD | PMID:12565868 |
| cisplatin | multiple interactions | ISO | RGD:69147 | 6480464 | [TNFSF10 protein co-treated with Cisplatin] results in increased activity of CASP9 protein | CTD | PMID:21252285 |
| cisplatin | multiple interactions | ISO | RGD:69147 | 6480464 | SMG1 protein inhibits the reaction [Cisplatin results in increased activity of CASP9 protein] | CTD | PMID:21418860 |
| cisplatin | multiple interactions | ISO | RGD:69147 | 6480464 | MYC protein promotes the reaction [Cisplatin results in increased cleavage of CASP9 protein] | CTD | PMID:21324178 |
| cisplatin | multiple interactions | ISO | RGD:69147 | 6480464 | Sirolimus promotes the reaction [Cisplatin results in increased cleavage of CASP9 protein] | CTD | PMID:18058806 |
| cisplatin | multiple interactions | ISO | RGD:69147 | 6480464 | ING4 protein promotes the reaction [Cisplatin results in increased activity of CASP9 protein] | CTD | PMID:21052098 |
| cisplatin | multiple interactions | ISO | RGD:69147 | 6480464 | [Fluorouracil co-treated with Cisplatin] results in increased activity of CASP9 protein; more ... | CTD | PMID:16803524 |
| cisplatin | increases expression | ISO | RGD:69147 | 6480464 | Cisplatin results in increased expression of CASP9 protein | CTD | PMID:16803524 |
| cisplatin | multiple interactions | ISO | RGD:69147 | 6480464 | CXCL2 protein promotes the reaction [Cisplatin results in increased activity of CASP9 protein]; more ... | CTD | PMID:21271225 |
| cisplatin | multiple interactions | ISO | RGD:69147 | 6480464 | [Deoxyglucose co-treated with Cisplatin] results in increased activity of CASP9 protein; more ... | CTD | PMID:20138251 |
| cisplatin | increases cleavage | ISO | RGD:69147 | 6480464 | Cisplatin results in increased cleavage of CASP9 protein | CTD | PMID:15496615 more ... |
| cisplatin | increases activity | ISO | RGD:69147 | 6480464 | Cisplatin results in increased activity of CASP9 protein | CTD | PMID:21166495 more ... |
| cisplatin | multiple interactions | ISO | RGD:69147 | 6480464 | Cisplatin results in increased expression of and results in increased cleavage of CASP9 protein; more ... | CTD | PMID:20674069 |
| cisplatin | decreases expression | ISO | RGD:69147 | 6480464 | Cisplatin results in decreased expression of CASP9 mRNA | CTD | PMID:17404015 |
| cisplatin | multiple interactions | ISO | RGD:69147 | 6480464 | [Cisplatin co-treated with fisetin] promotes the reaction [CASP9 protein results in increased cleavage of CASP7 protein]; more ... | CTD | PMID:21216935 |
| cisplatin | multiple interactions | ISO | RGD:69147 | 6480464 | [Cisplatin co-treated with Etoposide] results in increased activity of CASP9 protein; more ... | CTD | PMID:18676776 |
| cisplatin | multiple interactions | ISO | RGD:69147 | 6480464 | [Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased cleavage of CASP9 protein | CTD | PMID:21214929 |
| cisplatin | multiple interactions | ISO | RGD:69147 | 6480464 | BMI1 protein inhibits the reaction [Cisplatin results in increased activity of CASP9 protein] | CTD | PMID:21311599 |
| cisplatin | multiple interactions | ISO | RGD:69147 | 6480464 | beta-solamarine promotes the reaction [Cisplatin results in increased activity of CASP9 protein] | CTD | PMID:17619073 |
| cisplatin | multiple interactions | ISO | RGD:69147 | 6480464 | BCL2 inhibits the reaction [Cisplatin results in increased cleavage of CASP9 protein] | CTD | PMID:21618512 |
| cisplatin | multiple interactions | ISO | RGD:69147 | 6480464 | Acetylcysteine inhibits the reaction [Cisplatin results in increased cleavage of CASP9 protein] | CTD | PMID:15496615 |
| cisplatin | multiple interactions | ISO | RGD:69147 | 6480464 | Acetylcysteine inhibits the reaction [Cisplatin results in increased activity of CASP9 protein]; more ... | CTD | PMID:21166495 |
| cisplatin | multiple interactions | ISO | RGD:69147 | 6480464 | [4-methylene-2-octyl-5-oxofuran-3-carboxylic acid co-treated with Cisplatin] results in increased activity of CASP9 protein | CTD | PMID:21442130 |
| cladribine | multiple interactions | ISO | RGD:69147 | 6480464 | Cladribine promotes the reaction [bendamustine results in increased activity of CASP9 protein] | CTD | PMID:12948851 |
| cladribine | increases activity | ISO | RGD:69147 | 6480464 | Cladribine results in increased activity of CASP9 protein | CTD | PMID:11672427 PMID:12948851 |
| cladribine | increases activity | ISO | RGD:69147 | 6480464 | Cladribine results in increased activity of CASP9 protein | CTD | PMID:12948851 PMID:11672427 |
| cladribine | multiple interactions | ISO | RGD:69147 | 6480464 | BCL2 affects the reaction [Cladribine results in increased cleavage of and results in increased activity of CASP9 protein] | CTD | PMID:15516989 |
| clofarabine | multiple interactions | ISO | RGD:69147 | 6480464 | [clofarabine co-treated with fludarabine co-treated with Busulfan] results in increased cleavage of CASP9 protein | CTD | PMID:20933509 |
| clofibrate | decreases expression | ISO | RGD:62159 | 6480464 | Clofibrate results in decreased expression of CASP9 mRNA | CTD | PMID:17585979 |
| cocaine | affects expression | ISO | RGD:62159 | 6480464 | Cocaine affects the expression of CASP9 mRNA | CTD | PMID:15681117 |
| cocaine | increases activity | EXP | | 6480464 | Cocaine results in increased activity of CASP9 protein | CTD | PMID:10604926 more ... |
| cocaine | increases activity | EXP | | 6480464 | Cocaine results in increased activity of CASP9 protein | CTD | PMID:12639677 more ... |
| cocaine | increases activity | EXP | | 6480464 | Cocaine results in increased activity of CASP9 protein | CTD | PMID:18974856 more ... |
| cocaine | increases activity | EXP | | 6480464 | Cocaine results in increased activity of CASP9 protein | CTD | PMID:11392460 more ... |
| cocaine | increases activity | EXP | | 6480464 | Cocaine results in increased activity of CASP9 protein | CTD | PMID:18974856 more ... |
| cocaine | increases activity | EXP | | 6480464 | Cocaine results in increased activity of CASP9 protein | CTD | PMID:17635674 more ... |
| cocaine | multiple interactions | EXP | | 6480464 | SB 203580 inhibits the reaction [Cocaine results in increased activity of CASP9 protein] | CTD | PMID:15365088 |
| cocaine | affects expression | EXP | | 6480464 | Cocaine affects the expression of CASP9 protein | CTD | PMID:16179556 |
| cocaine | increases activity | EXP | | 6480464 | Cocaine results in increased activity of CASP9 protein | CTD | PMID:11392460 more ... |
| cocaine | increases expression | ISO | RGD:69147 | 6480464 | Cocaine results in increased expression of CASP9 protein | CTD | PMID:16686379 |
| codeinone | increases activity | ISO | RGD:69147 | 6480464 | 6-codeinone results in increased activity of CASP9 protein | CTD | PMID:12894543 |
| copper atom | multiple interactions | ISO | RGD:69147 | 6480464 | [Thiosemicarbazones binds to Copper] which results in increased expression of CASP9 protein | CTD | PMID:20931265 |
| copper atom | multiple interactions | ISO | RGD:69147 | 6480464 | [[Ditiocarb binds to Copper] which affects the localization of CYCS protein] promotes the reaction [[[CYCS protein binds to APAF1 protein binds to CASP9 protein] which results in increased metabolism of and results in increased activity of CASP9 protein] which results in increased activity of CASP3 protein] | CTD | PMID:22951949 |
| copper atom | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] results in increased cleavage of CASP9 protein] | CTD | PMID:22085843 |
| copper atom | multiple interactions | ISO | RGD:69147 | 6480464 | [Copper binds to Isatin binds to 2-(2-aminoethyl)pyridine] which results in increased cleavage of CASP9 protein; more ... | CTD | PMID:17327230 |
| copper atom | increases activity | ISO | RGD:62159 | 6480464 | Copper analog results in increased activity of CASP9 protein | CTD | PMID:22000994 |
| copper(0) | multiple interactions | ISO | RGD:69147 | 6480464 | [Thiosemicarbazones binds to Copper] which results in increased expression of CASP9 protein | CTD | PMID:20931265 |
| copper(0) | multiple interactions | ISO | RGD:69147 | 6480464 | [[Ditiocarb binds to Copper] which affects the localization of CYCS protein] promotes the reaction [[[CYCS protein binds to APAF1 protein binds to CASP9 protein] which results in increased metabolism of and results in increased activity of CASP9 protein] which results in increased activity of CASP3 protein] | CTD | PMID:22951949 |
| copper(0) | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] results in increased cleavage of CASP9 protein] | CTD | PMID:22085843 |
| copper(0) | multiple interactions | ISO | RGD:69147 | 6480464 | [Copper binds to Isatin binds to 2-(2-aminoethyl)pyridine] which results in increased cleavage of CASP9 protein; more ... | CTD | PMID:17327230 |
| copper(0) | increases activity | ISO | RGD:62159 | 6480464 | Copper analog results in increased activity of CASP9 protein | CTD | PMID:22000994 |
| copper(2+) sulfate | multiple interactions | EXP | | 6480464 | andrographolide inhibits the reaction [Copper Sulfate results in increased activity of CASP9 protein]; more ... | CTD | PMID:20946909 |
| copper(2+) sulfate | increases activity | EXP | | 6480464 | Copper Sulfate results in increased activity of CASP9 protein | CTD | PMID:20946909 |
| copper(II) chloride | multiple interactions | EXP | | 6480464 | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [[cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in increased cleavage of CASP9 protein]; more ... | CTD | PMID:20920558 |
| cordycepin | multiple interactions | ISO | RGD:69147 | 6480464 | Acetylcysteine inhibits the reaction [cordycepin results in increased activity of CASP9 protein] | CTD | PMID:21310227 |
| cordycepin | increases activity | ISO | RGD:69147 | 6480464 | cordycepin results in increased activity of CASP9 protein | CTD | PMID:21310227 PMID:21933677 |
| crocidolite asbestos | multiple interactions | ISO | RGD:62159 | 6480464 | rottlerin inhibits the reaction [Asbestos, Crocidolite results in increased cleavage of CASP9 protein] | CTD | PMID:12626342 |
| crocidolite asbestos | increases cleavage | ISO | RGD:62159 | 6480464 | Asbestos, Crocidolite results in increased cleavage of CASP9 protein | CTD | PMID:12626342 |
| curcumin | decreases expression | ISO | RGD:69147 | 6480464 | Curcumin results in decreased expression of CASP9 mRNA | CTD | PMID:16101141 |
| curcumin | multiple interactions | ISO | RGD:69147 | 6480464 | [Curcumin co-treated with arsenic trioxide] results in increased cleavage of CASP9 protein; more ... | CTD | PMID:20605902 |
| curcumin | multiple interactions | EXP | | 6480464 | Curcumin inhibits the reaction [Peroxynitrous Acid results in increased cleavage of and results in increased activity of CASP9 protein]; more ... | CTD | PMID:20869986 |
| curcumin | increases cleavage | ISO | RGD:69147 | 6480464 | Curcumin results in increased cleavage of CASP9 protein | CTD | PMID:21594647 PMID:14555224 |
| curcumin | multiple interactions | ISO | RGD:62159 | 6480464 | [Curcumin co-treated with gemcitabine] results in decreased expression of CASP9 protein | CTD | PMID:17440100 |
| curcumin | increases activity | EXP | | 6480464 | Curcumin results in increased activity of CASP9 protein | CTD | PMID:19095035 |
| curcumin | increases expression | ISO | RGD:69147 | 6480464 | Curcumin results in increased expression of CASP9 protein | CTD | PMID:18555241 |
| curcumin | multiple interactions | ISO | RGD:62159 | 6480464 | Curcumin results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:17277231 |
| curcumin | increases cleavage | ISO | RGD:69147 | 6480464 | Curcumin results in increased cleavage of CASP9 protein | CTD | PMID:14555224 PMID:21594647 |
| curcumin | multiple interactions | ISO | RGD:69147 | 6480464 | Curcumin results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:16023083 |
| curcumin | increases activity | ISO | RGD:69147 | 6480464 | Curcumin results in increased activity of CASP9 protein | CTD | PMID:17671742 |
| curcumin | multiple interactions | ISO | RGD:69147 | 6480464 | [Curcumin co-treated with Sirolimus] results in increased activity of CASP9 protein | CTD | PMID:19373661 |
| curcumin | decreases expression | ISO | RGD:69147 | 6480464 | Curcumin results in decreased expression of CASP9 protein | CTD | PMID:17148446 |
| cycloheximide | multiple interactions | ISO | RGD:69147 | 6480464 | [Cycloheximide co-treated with TNF] results in increased activity of CASP9 protein; more ... | CTD | PMID:12925536 |
| cycloheximide | multiple interactions | ISO | RGD:69147 | 6480464 | [Cycloheximide co-treated with TNFSF10 protein] results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:18222423 |
| cycloheximide | increases activity | ISO | RGD:62159 | 6480464 | Cycloheximide results in increased activity of CASP9 protein | CTD | PMID:14502240 |
| cyclophosphamide | multiple interactions | ISO | RGD:69147 | 6480464 | BCL2 protein inhibits the reaction [Cyclophosphamide results in increased activity of CASP9 protein] | CTD | PMID:11723234 |
| cyclophosphamide | increases activity | EXP | | 6480464 | Cyclophosphamide results in increased activity of CASP9 protein | CTD | PMID:11723234 |
| cyclophosphamide | multiple interactions | ISO | RGD:69147 | 6480464 | Cyclophosphamide results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:17898787 |
| cyclosporin A | multiple interactions | ISO | RGD:69147 | 6480464 | Cyclosporine inhibits the reaction [FAS protein results in increased activity of CASP9 protein] | CTD | PMID:15548389 |
| cyclosporin A | multiple interactions | ISO | RGD:62159 | 6480464 | Cyclosporine results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:22155090 |
| cyclosporin A | multiple interactions | ISO | RGD:69147 | 6480464 | Cyclosporine inhibits the reaction [brucine results in increased activity of and results in increased cleavage of CASP9 protein]; more ... | CTD | PMID:16443926 |
| cypermethrin | multiple interactions | EXP | | 6480464 | cypermethrin results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:22048644 |
| D-glucitol | increases activity | EXP | | 6480464 | Sorbitol results in increased activity of CASP9 protein | CTD | PMID:20609311 |
| D-glucitol | multiple interactions | EXP | | 6480464 | Spironolactone inhibits the reaction [Testosterone inhibits the reaction [Sorbitol results in increased activity of CASP9 protein]] | CTD | PMID:20609311 |
| D-glucose | multiple interactions | ISO | RGD:69147 | 6480464 | [Glucose deficiency co-treated with Acetylcysteine] results in increased activity of CASP9 protein; more ... | CTD | PMID:17309078 |
| D-glucose | increases activity | EXP | | 6480464 | Glucose results in increased activity of CASP9 | CTD | PMID:18791325 |
| D-glucose | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [Glucose results in increased activity of CASP9] | CTD | PMID:18791325 |
| D-mannitol | increases activity | ISO | RGD:69147 | 6480464 | Mannitol results in increased activity of CASP9 protein | CTD | PMID:12011046 |
| D-penicillamine | multiple interactions | EXP | | 6480464 | andrographolide promotes the reaction [Penicillamine inhibits the reaction [Copper Sulfate results in increased activity of CASP9 protein]]; more ... | CTD | PMID:20946909 |
| dasatinib (anhydrous) | increases activity | ISO | RGD:69147 | 6480464 | dasatinib results in increased activity of CASP9 protein | CTD | PMID:19398150 |
| dasatinib (anhydrous) | increases cleavage | ISO | RGD:69147 | 6480464 | dasatinib results in increased cleavage of CASP9 protein | CTD | PMID:18550857 |
| DDE | increases activity | ISO | RGD:69147 | 6480464 | Dichlorodiphenyl Dichloroethylene results in increased activity of CASP9 protein | CTD | PMID:19545618 |
| DDE | increases expression | EXP | | 6480464 | Dichlorodiphenyl Dichloroethylene results in increased expression of CASP9 mRNA | CTD | PMID:21384494 |
| deoxycholic acid | multiple interactions | ISO | RGD:69147 | 6480464 | Aspirin inhibits the reaction [Deoxycholic Acid results in increased activity of CASP9 protein] | CTD | PMID:17644113 |
| deoxycholic acid | increases cleavage | ISO | RGD:69147 | 6480464 | Deoxycholic Acid results in increased cleavage of CASP9 protein | CTD | PMID:21362092 |
| deoxycholic acid | multiple interactions | ISO | RGD:69147 | 6480464 | cobaltiprotoporphyrin inhibits the reaction [Deoxycholic Acid results in increased cleavage of CASP9 protein] | CTD | PMID:21362092 |
| deoxycholic acid | increases activity | ISO | RGD:69147 | 6480464 | Deoxycholic Acid results in increased activity of CASP9 protein | CTD | PMID:17644113 |
| desipramine | increases activity | EXP | | 6480464 | Desipramine results in increased activity of CASP9 protein | CTD | PMID:20549303 |
| dexamethasone | increases activity | ISO | RGD:69147 | 6480464 | Dexamethasone results in increased activity of CASP9 protein | CTD | PMID:15574755 PMID:15576458 |
| dexamethasone | increases activity | ISO | RGD:69147 | 6480464 | Dexamethasone results in increased activity of CASP9 protein | CTD | PMID:15576458 PMID:15574755 |
| dexamethasone | multiple interactions | EXP | | 6480464 | Dexamethasone inhibits the reaction [TGFB1 protein results in increased activity of CASP9 protein] | CTD | PMID:15388240 |
| dexamethasone | multiple interactions | ISO | RGD:62159 | 6480464 | Spermine inhibits the reaction [Dexamethasone results in increased activity of CASP9 protein] | CTD | PMID:11399061 |
| dexamethasone | increases activity | ISO | RGD:62159 | 6480464 | Dexamethasone results in increased activity of CASP9 protein | CTD | PMID:11399061 |
| dexamethasone | multiple interactions | ISO | RGD:69147 | 6480464 | isocoumarin NM-3 promotes the reaction [Dexamethasone results in increased activity of CASP9 protein] | CTD | PMID:15574755 |
| dexamethasone | decreases expression | ISO | RGD:62159 | 6480464 | Dexamethasone results in decreased expression of CASP9 mRNA | CTD | PMID:15944155 |
| dexamethasone | increases cleavage | ISO | RGD:69147 | 6480464 | Dexamethasone results in increased cleavage of CASP9 protein | CTD | PMID:16445836 |
| dexmedetomidine | increases activity | ISO | RGD:69147 | 6480464 | Dexmedetomidine results in increased activity of CASP9 protein | CTD | PMID:18724006 |
| diallyl disulfide | increases activity | ISO | RGD:69147 | 6480464 | diallyl disulfide results in increased activity of CASP9 protein | CTD | PMID:14522920 |
| diarsenic trioxide | increases activity | ISO | RGD:69147 | 6480464 | arsenic trioxide results in increased activity of CASP9 protein | CTD | PMID:20953137 more ... |
| diarsenic trioxide | multiple interactions | ISO | RGD:69147 | 6480464 | TNF protein promotes the reaction [arsenic trioxide results in increased activity of CASP9 protein] | CTD | PMID:17673311 |
| diarsenic trioxide | multiple interactions | ISO | RGD:69147 | 6480464 | STMN1 inhibits the reaction [arsenic trioxide results in increased cleavage of CASP9 protein] | CTD | PMID:20657188 |
| diarsenic trioxide | multiple interactions | ISO | RGD:69147 | 6480464 | Fluorouracil promotes the reaction [arsenic trioxide results in decreased expression of CASP9 protein] | CTD | PMID:22963400 |
| diarsenic trioxide | increases activity | ISO | RGD:69147 | 6480464 | arsenic trioxide results in increased activity of CASP9 protein | CTD | PMID:12148893 more ... |
| diarsenic trioxide | decreases expression | ISO | RGD:69147 | 6480464 | arsenic trioxide results in decreased expression of CASP9 protein | CTD | PMID:22963400 |
| diarsenic trioxide | increases cleavage | ISO | RGD:69147 | 6480464 | arsenic trioxide results in increased cleavage of CASP9 protein | CTD | PMID:12480548 more ... |
| diarsenic trioxide | multiple interactions | ISO | RGD:69147 | 6480464 | [Curcumin co-treated with arsenic trioxide] results in increased cleavage of CASP9 protein | CTD | PMID:20605902 |
| diarsenic trioxide | multiple interactions | ISO | RGD:69147 | 6480464 | Genistein promotes the reaction [arsenic trioxide results in increased activity of CASP9 protein] | CTD | PMID:20219070 |
| diarsenic trioxide | increases cleavage | ISO | RGD:69147 | 6480464 | arsenic trioxide results in increased cleavage of CASP9 protein | CTD | PMID:12480548 more ... |
| diarsenic trioxide | multiple interactions | ISO | RGD:69147 | 6480464 | arsenic trioxide results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:17374990 more ... |
| diarsenic trioxide | increases activity | ISO | RGD:69147 | 6480464 | arsenic trioxide results in increased activity of CASP9 protein | CTD | PMID:12148893 more ... |
| diarsenic trioxide | multiple interactions | ISO | RGD:69147 | 6480464 | arsenic trioxide promotes the reaction [lonidamine results in increased cleavage of and results in increased activity of CASP9 protein]; more ... | CTD | PMID:21889928 |
| diarsenic trioxide | increases activity | EXP | | 6480464 | arsenic trioxide results in increased activity of CASP9 protein | CTD | PMID:21145380 |
| diarsenic trioxide | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [arsenic trioxide results in increased activity of CASP9 protein] | CTD | PMID:21145380 |
| diarsenic trioxide | increases activity | ISO | RGD:69147 | 6480464 | arsenic trioxide results in increased activity of CASP9 protein | CTD | PMID:12148893 more ... |
| diarsenic trioxide | increases cleavage | ISO | RGD:69147 | 6480464 | arsenic trioxide results in increased cleavage of CASP9 protein | CTD | PMID:18387645 more ... |
| diarsenic trioxide | increases activity | ISO | RGD:62159 | 6480464 | arsenic trioxide results in increased activity of CASP9 protein | CTD | PMID:21565247 |
| diarsenic trioxide | increases activity | ISO | RGD:69147 | 6480464 | arsenic trioxide results in increased activity of CASP9 protein | CTD | PMID:21061466 more ... |
| diarsenic trioxide | increases cleavage | ISO | RGD:69147 | 6480464 | arsenic trioxide results in increased cleavage of CASP9 protein | CTD | PMID:21655183 more ... |
| diarsenic trioxide | increases cleavage | ISO | RGD:69147 | 6480464 | arsenic trioxide results in increased cleavage of CASP9 protein | CTD | PMID:21655183 more ... |
| diarsenic trioxide | increases activity | ISO | RGD:69147 | 6480464 | arsenic trioxide results in increased activity of CASP9 protein | CTD | PMID:20138156 more ... |
| diarsenic trioxide | increases cleavage | ISO | RGD:69147 | 6480464 | arsenic trioxide results in increased cleavage of CASP9 protein | CTD | PMID:18491231 more ... |
| diarsenic trioxide | multiple interactions | ISO | RGD:69147 | 6480464 | arsenic trioxide results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:19695276 PMID:19408305 |
| diarsenic trioxide | increases activity | ISO | RGD:69147 | 6480464 | arsenic trioxide results in increased activity of CASP9 protein | CTD | PMID:16010437 more ... |
| diarsenic trioxide | increases expression | EXP | | 6480464 | arsenic trioxide results in increased expression of CASP9 mRNA | CTD | PMID:19730151 |
| diarsenic trioxide | multiple interactions | ISO | RGD:62159 | 6480464 | arsenic trioxide results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:15688020 |
| diarsenic trioxide | decreases expression | ISO | RGD:62159 | 6480464 | arsenic trioxide results in decreased expression of CASP9 protein | CTD | PMID:18336854 |
| diarsenic trioxide | multiple interactions | ISO | RGD:69147 | 6480464 | [Sulindac co-treated with arsenic trioxide] results in increased activity of CASP9 protein | CTD | PMID:18281123 |
| diarsenic trioxide | multiple interactions | ISO | RGD:62159 | 6480464 | Acetylcysteine inhibits the reaction [arsenic trioxide results in decreased expression of CASP9 protein] | CTD | PMID:18336854 |
| diarsenic trioxide | multiple interactions | ISO | RGD:69147 | 6480464 | MAPK8 protein affects the reaction [arsenic trioxide results in increased activity of CASP9 protein] | CTD | PMID:20534739 |
| diarsenic trioxide | multiple interactions | ISO | RGD:69147 | 6480464 | bortezomib promotes the reaction [arsenic trioxide results in increased activity of CASP9 protein] | CTD | PMID:20471514 |
| diarsenic trioxide | increases cleavage | ISO | RGD:69147 | 6480464 | arsenic trioxide results in increased cleavage of CASP9 protein | CTD | PMID:18387645 more ... |
| diarsenic trioxide | multiple interactions | ISO | RGD:69147 | 6480464 | arsenic trioxide results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:19408305 PMID:19695276 |
| diarsenic trioxide | increases activity | ISO | RGD:69147 | 6480464 | arsenic trioxide results in increased activity of CASP9 protein | CTD | PMID:12492118 more ... |
| diarsenic trioxide | multiple interactions | ISO | RGD:69147 | 6480464 | ARL6IP5 protein promotes the reaction [arsenic trioxide results in increased cleavage of CASP9 protein] | CTD | PMID:18387645 |
| diarsenic trioxide | multiple interactions | ISO | RGD:69147 | 6480464 | AKT1 mutant form promotes the reaction [arsenic trioxide results in increased cleavage of CASP9 protein]; more ... | CTD | PMID:21655183 |
| diarsenic trioxide | multiple interactions | ISO | RGD:69147 | 6480464 | 3,4-dihydro-5-(4-(1-piperidinyl)butoxy)-1(2H)-isoquinolinone inhibits the reaction [[arsenic trioxide co-treated with phytosphingosine] results in increased activity of CASP9 protein]; more ... | CTD | PMID:17237268 |
| diarsenic trioxide | multiple interactions | ISO | RGD:69147 | 6480464 | Acetylcysteine inhibits the reaction [arsenic trioxide results in increased activity of CASP9 protein] | CTD | PMID:19771260 |
| diarsenic trioxide | multiple interactions | ISO | RGD:69147 | 6480464 | Acetylcysteine inhibits the reaction [arsenic trioxide promotes the reaction [Poly I-C results in increased activity of CASP9 protein]]; more ... | CTD | PMID:21418039 |
| diarsenic trioxide | increases cleavage | ISO | RGD:69147 | 6480464 | arsenic trioxide results in increased cleavage of CASP9 protein | CTD | PMID:18491231 more ... |
| diarsenic trioxide | increases activity | ISO | RGD:69147 | 6480464 | arsenic trioxide results in increased activity of CASP9 protein | CTD | PMID:21418039 more ... |
| diarsenic trioxide | multiple interactions | ISO | RGD:69147 | 6480464 | 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin promotes the reaction [arsenic trioxide results in increased cleavage of CASP9 protein]; more ... | CTD | PMID:19371599 |
| diazinon | affects expression | EXP | | 6480464 | Diazinon affects the expression of CASP9 mRNA | CTD | PMID:17452286 |
| dichlorvos | multiple interactions | EXP | | 6480464 | [Vitamin E co-treated with Ascorbic Acid] inhibits the reaction [Dichlorvos results in increased activity of CASP9 protein] | CTD | PMID:16973328 |
| dichlorvos | increases activity | EXP | | 6480464 | Dichlorvos results in increased activity of CASP9 protein | CTD | PMID:16973328 |
| diclofenac | multiple interactions | ISO | RGD:69147 | 6480464 | Diclofenac inhibits the reaction [Thapsigargin results in increased activity of CASP9 protein]; more ... | CTD | PMID:16388830 |
| diclofenac | increases activity | EXP | | 6480464 | Diclofenac results in increased activity of CASP9 protein | CTD | PMID:14609740 |
| dieldrin | increases activity | EXP | | 6480464 | Dieldrin results in increased activity of CASP9 protein | CTD | PMID:12831855 |
| diepoxybutane | multiple interactions | ISO | RGD:69147 | 6480464 | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [erythritol anhydride results in increased activity of CASP9 protein] | CTD | PMID:14998682 |
| diepoxybutane | increases activity | ISO | RGD:69147 | 6480464 | erythritol anhydride results in increased activity of CASP9 protein | CTD | PMID:14998682 |
| diethyl maleate | increases expression | ISO | RGD:69147 | 6480464 | diethyl maleate results in increased expression of CASP9 mRNA | CTD | PMID:11875189 |
| digitoxin | increases cleavage | ISO | RGD:69147 | 6480464 | Digitoxin analog results in increased cleavage of CASP9 protein; more ... | CTD | PMID:22037315 |
| dihydrolipoic acid | increases activity | ISO | RGD:62159 | 6480464 | dihydrolipoic acid results in increased activity of CASP9 protein | CTD | PMID:21462292 |
| dihydrolipoic acid | multiple interactions | ISO | RGD:62159 | 6480464 | 2-phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide inhibits the reaction [dihydrolipoic acid results in increased activity of CASP9 protein] | CTD | PMID:21462292 |
| dimethylarsinic acid | multiple interactions | EXP | | 6480464 | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [CASP9 protein results in increased susceptibility to Cacodylic Acid] | CTD | PMID:15276415 |
| dimethylarsinic acid | increases response to substance | EXP | | 6480464 | CASP9 protein results in increased susceptibility to Cacodylic Acid | CTD | PMID:15276415 |
| dioxygen | multiple interactions | ISO | RGD:69147 | 6480464 | 5,6-dihydro-5-(1-piperidinyl)methyl-3-(3-pyridil)-4H-1,2,4-oxa-diazine inhibits the reaction [Oxygen deficiency results in increased activity of CASP9 protein]; more ... | CTD | PMID:15583868 |
| dioxygen | increases cleavage | EXP | | 6480464 | Oxygen deficiency results in increased cleavage of CASP9 protein | CTD | PMID:15786717 PMID:21468576 |
| dioxygen | increases cleavage | EXP | | 6480464 | Oxygen deficiency results in increased cleavage of CASP9 protein | CTD | PMID:21468576 PMID:15786717 |
| dioxygen | increases cleavage | EXP | | 6480464 | Oxygen deficiency results in increased cleavage of CASP9 protein | CTD | PMID:15786717 |
| dioxygen | affects response to substance | EXP | | 6480464 | CASP9 protein affects the susceptibility to Oxygen deficiency | CTD | PMID:11042672 |
| dioxygen | increases activity | ISO | RGD:69147 | 6480464 | Oxygen deficiency results in increased activity of CASP9 protein | CTD | PMID:15583868 |
| diquat | multiple interactions | ISO | RGD:62159 | 6480464 | Diquat results in increased cleavage of and results in increased activity of CASP9 protein; more ... | CTD | PMID:18164269 |
| diquat | increases cleavage | ISO | RGD:62159 | 6480464 | Diquat results in increased cleavage of CASP9 protein | CTD | PMID:20826540 |
| diquat | multiple interactions | ISO | RGD:62159 | 6480464 | PROP1 protein affects the reaction [Diquat results in increased cleavage of CASP9 protein] | CTD | PMID:20826540 |
| disodium selenite | increases expression | ISO | RGD:69147 | 6480464 | Sodium Selenite results in increased expression of CASP9 mRNA | CTD | PMID:16705456 |
| disodium selenite | decreases activity | EXP | | 6480464 | Sodium Selenite results in decreased activity of CASP9 protein | CTD | PMID:18209489 |
| divanadium pentaoxide | increases activity | EXP | | 6480464 | vanadium pentoxide results in increased activity of CASP9 protein | CTD | PMID:19646462 |
| docetaxel anhydrous | multiple interactions | ISO | RGD:69147 | 6480464 | docetaxel promotes the reaction [celecoxib results in increased cleavage of and results in increased activity of CASP9 protein]; more ... | CTD | PMID:15688368 |
| docetaxel anhydrous | multiple interactions | ISO | RGD:69147 | 6480464 | docetaxel results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:17308071 PMID:15688368 |
| docetaxel anhydrous | multiple interactions | ISO | RGD:69147 | 6480464 | docetaxel results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:15688368 PMID:17308071 |
| docetaxel anhydrous | multiple interactions | ISO | RGD:69147 | 6480464 | benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone inhibits the reaction [docetaxel results in increased cleavage of and results in increased activity of CASP9 protein] | CTD | PMID:17308071 |
| donepezil hydrochloride | increases activity | ISO | RGD:69147 | 6480464 | donepezil results in increased activity of CASP9 protein | CTD | PMID:20522977 |
| doxorubicin | multiple interactions | ISO | RGD:69147 | 6480464 | BCL2L11 protein promotes the reaction [[Doxorubicin co-treated with Selenium] results in increased cleavage of and results in increased activity of CASP9 protein]; more ... | CTD | PMID:17339365 |
| doxorubicin | increases activity | ISO | RGD:69147 | 6480464 | Doxorubicin results in increased activity of CASP9 protein | CTD | PMID:11779855 more ... |
| doxorubicin | increases cleavage | ISO | RGD:69147 | 6480464 | Doxorubicin results in increased cleavage of CASP9 protein | CTD | PMID:15555623 more ... |
| doxorubicin | multiple interactions | ISO | RGD:69147 | 6480464 | Doxorubicin results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:16024631 more ... |
| doxorubicin | multiple interactions | EXP | | 6480464 | Doxorubicin results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:16687611 more ... |
| doxorubicin | multiple interactions | EXP | | 6480464 | Doxorubicin results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:17651020 more ... |
| doxorubicin | increases activity | EXP | | 6480464 | Doxorubicin results in increased activity of CASP9 protein | CTD | PMID:16357363 more ... |
| doxorubicin | increases activity | ISO | RGD:62159 | 6480464 | Doxorubicin results in increased activity of CASP9 protein | CTD | PMID:19767621 more ... |
| doxorubicin | increases cleavage | ISO | RGD:69147 | 6480464 | Doxorubicin results in increased cleavage of CASP9 protein | CTD | PMID:17283156 more ... |
| doxorubicin | multiple interactions | ISO | RGD:69147 | 6480464 | Doxorubicin results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:16364925 more ... |
| doxorubicin | increases activity | ISO | RGD:69147 | 6480464 | Doxorubicin results in increased activity of CASP9 protein | CTD | PMID:22609468 more ... |
| doxorubicin | increases expression | ISO | RGD:69147 | 6480464 | Doxorubicin results in increased expression of CASP9 mRNA | CTD | PMID:16001973 more ... |
| doxorubicin | multiple interactions | ISO | RGD:69147 | 6480464 | Doxorubicin results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:16024631 more ... |
| doxorubicin | increases cleavage | ISO | RGD:69147 | 6480464 | Doxorubicin results in increased cleavage of CASP9 protein | CTD | PMID:16311509 more ... |
| doxorubicin | increases activity | EXP | | 6480464 | Doxorubicin results in increased activity of CASP9 protein | CTD | PMID:16357363 more ... |
| doxorubicin | multiple interactions | EXP | | 6480464 | Doxorubicin results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:17635642 more ... |
| doxorubicin | increases activity | ISO | RGD:69147 | 6480464 | Doxorubicin results in increased activity of CASP9 protein | CTD | PMID:17437844 more ... |
| doxorubicin | multiple interactions | ISO | RGD:69147 | 6480464 | [benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP9 protein] affects the reaction [SOD2 protein results in decreased susceptibility to Doxorubicin]; more ... | CTD | PMID:18594523 |
| doxorubicin | multiple interactions | EXP | | 6480464 | Doxorubicin results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:17651020 more ... |
| doxorubicin | increases activity | EXP | | 6480464 | Doxorubicin results in increased activity of CASP9 protein | CTD | PMID:19139834 more ... |
| doxorubicin | increases activity | ISO | RGD:62159 | 6480464 | Doxorubicin results in increased activity of CASP9 protein | CTD | PMID:16018998 more ... |
| doxorubicin | increases expression | ISO | RGD:69147 | 6480464 | Doxorubicin results in increased expression of CASP9 mRNA | CTD | PMID:16001973 more ... |
| doxorubicin | increases cleavage | ISO | RGD:69147 | 6480464 | Doxorubicin results in increased cleavage of CASP9 protein | CTD | PMID:17935137 more ... |
| doxorubicin | multiple interactions | ISO | RGD:69147 | 6480464 | Doxorubicin results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:17285121 more ... |
| doxorubicin | increases activity | ISO | RGD:69147 | 6480464 | Doxorubicin results in increased activity of CASP9 protein | CTD | PMID:15868924 more ... |
| doxorubicin | increases expression | ISO | RGD:69147 | 6480464 | Doxorubicin results in increased expression of CASP9 mRNA | CTD | PMID:15576332 more ... |
| doxorubicin | multiple interactions | EXP | | 6480464 | Doxorubicin results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:17285121 more ... |
| doxorubicin | increases activity | EXP | | 6480464 | Doxorubicin results in increased activity of CASP9 protein | CTD | PMID:16357363 more ... |
| doxorubicin | increases activity | ISO | RGD:62159 | 6480464 | Doxorubicin results in increased activity of CASP9 protein | CTD | PMID:19767621 more ... |
| doxorubicin | increases cleavage | ISO | RGD:69147 | 6480464 | Doxorubicin results in increased cleavage of CASP9 protein | CTD | PMID:15555623 more ... |
| doxorubicin | multiple interactions | ISO | RGD:69147 | 6480464 | Doxorubicin results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:17651020 more ... |
| doxorubicin | increases activity | ISO | RGD:69147 | 6480464 | Doxorubicin results in increased activity of CASP9 protein | CTD | PMID:20884855 more ... |
| doxorubicin | multiple interactions | EXP | | 6480464 | Doxorubicin results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:17635642 more ... |
| doxorubicin | increases activity | EXP | | 6480464 | Doxorubicin results in increased activity of CASP9 protein | CTD | PMID:15799720 more ... |
| doxorubicin | increases activity | ISO | RGD:62159 | 6480464 | Doxorubicin results in increased activity of CASP9 protein | CTD | PMID:16018998 more ... |
| doxorubicin | multiple interactions | ISO | RGD:69147 | 6480464 | MT3 protein inhibits the reaction [Doxorubicin results in increased activity of CASP9 protein] | CTD | PMID:19767621 |
| doxorubicin | increases cleavage | ISO | RGD:69147 | 6480464 | Doxorubicin results in increased cleavage of CASP9 protein | CTD | PMID:17935137 more ... |
| doxorubicin | increases activity | ISO | RGD:69147 | 6480464 | Doxorubicin results in increased activity of CASP9 protein | CTD | PMID:15981920 more ... |
| doxorubicin | multiple interactions | ISO | RGD:69147 | 6480464 | Doxorubicin results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:16024631 more ... |
| doxorubicin | multiple interactions | EXP | | 6480464 | 7-monohydroxyethylrutoside inhibits the reaction [Doxorubicin results in increased cleavage of and results in increased activity of CASP9 protein] | CTD | PMID:17285121 |
| doxorubicin | multiple interactions | EXP | | 6480464 | pifithrin inhibits the reaction [Doxorubicin results in increased activity of CASP9 protein] | CTD | PMID:16357363 |
| doxorubicin | multiple interactions | EXP | | 6480464 | pifithrin inhibits the reaction [Doxorubicin results in increased cleavage of CASP9 protein]; more ... | CTD | PMID:18775851 |
| doxorubicin | multiple interactions | EXP | | 6480464 | pifithrin inhibits the reaction [Doxorubicin results in increased cleavage of and results in increased activity of CASP9 protein] | CTD | PMID:16687611 |
| doxorubicin | multiple interactions | EXP | | 6480464 | NOL3 protein inhibits the reaction [Doxorubicin results in increased activity of CASP9 protein] | CTD | PMID:19139834 |
| doxorubicin | increases cleavage | EXP | | 6480464 | Doxorubicin results in increased cleavage of CASP9 protein | CTD | PMID:18775851 |
| doxorubicin | multiple interactions | EXP | | 6480464 | Doxorubicin results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:16687611 more ... |
| doxorubicin | increases activity | EXP | | 6480464 | Doxorubicin results in increased activity of CASP9 protein | CTD | PMID:19139834 more ... |
| doxorubicin | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [NRG1 protein inhibits the reaction [Doxorubicin results in increased activity of CASP9 protein]] | CTD | PMID:19801490 |
| doxorubicin | multiple interactions | ISO | RGD:62159 | 6480464 | [zoledronic acid co-treated with Doxorubicin] results in increased activity of CASP9 protein | CTD | PMID:19789217 |
| doxorubicin | increases activity | ISO | RGD:62159 | 6480464 | Doxorubicin results in increased activity of CASP9 protein | CTD | PMID:17481927 PMID:16018998 |
| doxorubicin | increases expression | ISO | RGD:62159 | 6480464 | Doxorubicin results in increased expression of CASP9 mRNA | CTD | PMID:19286953 |
| doxorubicin | multiple interactions | ISO | RGD:62159 | 6480464 | dicarbine inhibits the reaction [Doxorubicin results in increased activity of CASP9 protein] | CTD | PMID:17481927 |
| doxorubicin | multiple interactions | ISO | RGD:62159 | 6480464 | 5,10,15,20-tetrakis(N-methyl-4'-pyridyl)porphyrinato-iron(III) inhibits the reaction [Doxorubicin results in increased expression of CASP9 mRNA]; more ... | CTD | PMID:19286953 |
| doxorubicin | multiple interactions | ISO | RGD:69147 | 6480464 | wortmannin promotes the reaction [Doxorubicin results in increased cleavage of CASP9 protein] | CTD | PMID:17935137 |
| doxorubicin | multiple interactions | ISO | RGD:69147 | 6480464 | TNFRSF10A protein affects the reaction [Doxorubicin results in increased activity of CASP9 protein] | CTD | PMID:17437844 |
| doxorubicin | multiple interactions | ISO | RGD:69147 | 6480464 | TMSB4X protein inhibits the reaction [Doxorubicin results in increased cleavage of and results in increased activity of CASP9 protein] | CTD | PMID:16364925 |
| doxorubicin | multiple interactions | ISO | RGD:69147 | 6480464 | pluronic block copolymer p85 promotes the reaction [Doxorubicin results in increased expression of CASP9 mRNA] | CTD | PMID:15939500 |
| doxorubicin | multiple interactions | ISO | RGD:69147 | 6480464 | PRKDC protein affects the reaction [Doxorubicin results in increased activity of CASP9 protein]; more ... | CTD | PMID:18508926 |
| doxorubicin | multiple interactions | ISO | RGD:69147 | 6480464 | geldanamycin inhibits the reaction [Doxorubicin results in increased cleavage of CASP9 protein] | CTD | PMID:16311509 |
| doxorubicin | multiple interactions | ISO | RGD:69147 | 6480464 | [Indomethacin results in increased activity of CASP9 protein] which results in increased susceptibility to Doxorubicin | CTD | PMID:15812552 |
| doxorubicin | increases expression | ISO | RGD:69147 | 6480464 | Doxorubicin results in increased expression of CASP9 mRNA | CTD | PMID:15576332 more ... |
| doxorubicin | multiple interactions | ISO | RGD:69147 | 6480464 | Doxorubicin results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:16364925 more ... |
| doxorubicin | increases cleavage | ISO | RGD:69147 | 6480464 | Doxorubicin results in increased cleavage of CASP9 protein | CTD | PMID:17283156 more ... |
| doxorubicin | increases activity | ISO | RGD:69147 | 6480464 | Doxorubicin results in increased activity of CASP9 protein | CTD | PMID:15868924 more ... |
| doxorubicin | decreases expression | ISO | RGD:69147 | 6480464 | Doxorubicin results in decreased expression of CASP9 mRNA | CTD | PMID:17404015 |
| doxorubicin | multiple interactions | ISO | RGD:69147 | 6480464 | [Doxorubicin co-treated with Paclitaxel] results in increased activity of CASP9 protein; more ... | CTD | PMID:16168113 |
| doxorubicin | multiple interactions | ISO | RGD:69147 | 6480464 | [Doxorubicin co-treated with FAS protein] results in increased activity of CASP9 protein | CTD | PMID:15958570 |
| doxorubicin | multiple interactions | ISO | RGD:69147 | 6480464 | [Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased cleavage of CASP9 protein | CTD | PMID:21214929 |
| doxorubicin | increases activity | ISO | RGD:69147 | 6480464 | Doxorubicin analog results in increased activity of CASP9 protein | CTD | PMID:15981920 |
| doxorubicin | affects expression | ISO | RGD:69147 | 6480464 | Doxorubicin affects the expression of CASP9 mRNA | CTD | PMID:16705698 |
| doxorubicin | affects activity | ISO | RGD:69147 | 6480464 | Doxorubicin affects the activity of CASP9 protein | CTD | PMID:15870702 |
| doxorubicin | multiple interactions | ISO | RGD:69147 | 6480464 | CASP9 protein mutant form inhibits the reaction [sildenafil results in increased activity of Doxorubicin]; more ... | CTD | PMID:20884855 |
| doxorubicin | multiple interactions | ISO | RGD:69147 | 6480464 | CASP3 protein promotes the reaction [Doxorubicin results in increased cleavage of CASP9 protein] | CTD | PMID:17013758 |
| doxorubicin | multiple interactions | ISO | RGD:69147 | 6480464 | 7-monohydroxyethylrutoside inhibits the reaction [Doxorubicin results in increased cleavage of and results in increased activity of CASP9 protein] | CTD | PMID:17285121 |
| doxorubicin | multiple interactions | ISO | RGD:69147 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Doxorubicin results in increased cleavage of CASP9 protein]; more ... | CTD | PMID:20856197 |
| elemental selenium | multiple interactions | ISO | RGD:69147 | 6480464 | [Doxorubicin co-treated with Selenium] results in increased cleavage of and results in increased activity of CASP9 protein; more ... | CTD | PMID:17339365 |
| elemental selenium | multiple interactions | EXP | | 6480464 | [Vitamin E co-treated with Selenium] inhibits the reaction [Malathion results in increased expression of CASP9 mRNA] | CTD | PMID:21628957 |
| elemental selenium | decreases activity | ISO | RGD:62159 | 6480464 | Selenium results in decreased activity of CASP9 protein | CTD | PMID:17997286 |
| emetine | increases activity | ISO | RGD:62159 | 6480464 | Emetine results in increased activity of CASP9 protein | CTD | PMID:14502240 |
| enalapril | decreases activity | EXP | | 6480464 | Enalapril results in decreased activity of CASP9 protein | CTD | PMID:21153712 |
| ethylbenzene | increases expression | EXP | | 6480464 | ethylbenzene results in increased expression of CASP9 protein | CTD | PMID:20156836 |
| etodolac | increases activity | ISO | RGD:69147 | 6480464 | Etodolac results in increased activity of CASP9 protein | CTD | PMID:16104877 PMID:16046235 |
| etodolac | increases activity | ISO | RGD:69147 | 6480464 | Etodolac results in increased activity of CASP9 protein | CTD | PMID:16046235 PMID:16104877 |
| etoposide | multiple interactions | ISO | RGD:69147 | 6480464 | [CASP8 co-treated with TP53] affects the reaction [Etoposide results in increased cleavage of and results in increased activity of CASP9 protein]; more ... | CTD | PMID:21801448 |
| etoposide | multiple interactions | ISO | RGD:69147 | 6480464 | Etoposide results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:21801448 more ... |
| etoposide | increases cleavage | ISO | RGD:69147 | 6480464 | Etoposide results in increased cleavage of CASP9 protein | CTD | PMID:12925536 more ... |
| etoposide | multiple interactions | ISO | RGD:69147 | 6480464 | Etoposide results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:21745461 more ... |
| etoposide | increases cleavage | ISO | RGD:69147 | 6480464 | Etoposide results in increased cleavage of CASP9 protein | CTD | PMID:12925536 more ... |
| etoposide | multiple interactions | ISO | RGD:69147 | 6480464 | Etoposide results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:16364925 more ... |
| etoposide | increases cleavage | ISO | RGD:69147 | 6480464 | Etoposide results in increased cleavage of CASP9 protein | CTD | PMID:17935137 more ... |
| etoposide | increases cleavage | ISO | RGD:69147 | 6480464 | Etoposide results in increased cleavage of CASP9 protein | CTD | PMID:21324178 more ... |
| etoposide | multiple interactions | ISO | RGD:69147 | 6480464 | Etoposide results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:16364925 more ... |
| etoposide | multiple interactions | ISO | RGD:69147 | 6480464 | wortmannin promotes the reaction [Etoposide results in increased cleavage of CASP9 protein] | CTD | PMID:17935137 |
| etoposide | multiple interactions | ISO | RGD:69147 | 6480464 | TMSB4X protein inhibits the reaction [Etoposide results in increased cleavage of and results in increased activity of CASP9 protein] | CTD | PMID:16364925 |
| etoposide | multiple interactions | ISO | RGD:69147 | 6480464 | nimesulide inhibits the reaction [Etoposide results in increased cleavage of and results in increased activity of CASP9 protein] | CTD | PMID:21745461 |
| etoposide | multiple interactions | ISO | RGD:69147 | 6480464 | MYC protein promotes the reaction [Etoposide results in increased cleavage of CASP9 protein] | CTD | PMID:21324178 |
| etoposide | multiple interactions | ISO | RGD:69147 | 6480464 | HTATIP2 protein promotes the reaction [Etoposide results in increased activity of CASP9 protein] | CTD | PMID:16799960 |
| etoposide | increases cleavage | ISO | RGD:69147 | 6480464 | Etoposide results in increased cleavage of CASP9 protein | CTD | PMID:21324178 more ... |
| etoposide | multiple interactions | ISO | RGD:69147 | 6480464 | Etoposide results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:21745461 more ... |
| etoposide | increases activity | ISO | RGD:69147 | 6480464 | Etoposide results in increased activity of CASP9 protein | CTD | PMID:18056177 |
| etoposide | affects expression | ISO | RGD:69147 | 6480464 | Etoposide affects the expression of CASP9 protein | CTD | PMID:15215046 |
| etoposide | multiple interactions | ISO | RGD:69147 | 6480464 | [Cisplatin co-treated with Etoposide] results in increased activity of CASP9 protein; more ... | CTD | PMID:18676776 |
| eugenol | multiple interactions | ISO | RGD:62159 | 6480464 | Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of CASP9 protein] | CTD | PMID:20434464 |
| fipronil | increases activity | ISO | RGD:69147 | 6480464 | fipronil results in increased activity of CASP9 protein | CTD | PMID:22421270 |
| fisetin | multiple interactions | ISO | RGD:69147 | 6480464 | [Cisplatin co-treated with fisetin] promotes the reaction [CASP9 protein results in increased cleavage of CASP7 protein]; more ... | CTD | PMID:21216935 |
| flavanone | multiple interactions | ISO | RGD:69147 | 6480464 | flavanone results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:22056764 |
| formaldehyde | increases activity | ISO | RGD:69147 | 6480464 | Formaldehyde results in increased activity of CASP9 protein | CTD | PMID:20347000 |
| formaldehyde | multiple interactions | ISO | RGD:69147 | 6480464 | PRDX2 protein inhibits the reaction [Formaldehyde results in increased activity of CASP9 protein] | CTD | PMID:20347000 |
| furan | increases expression | EXP | | 6480464 | furan results in increased expression of CASP9 mRNA | CTD | PMID:20562052 |
| furosemide | affects expression | EXP | | 6480464 | Furosemide affects the expression of CASP9 mRNA | CTD | PMID:17497460 |
| gamma-hexachlorocyclohexane | increases expression | EXP | | 6480464 | Lindane results in increased expression of CASP9 protein | CTD | PMID:19038305 |
| gamma-hexachlorocyclohexane | multiple interactions | EXP | | 6480464 | Ro 31-8220 inhibits the reaction [Lindane results in increased activity of CASP9 protein]; more ... | CTD | PMID:22001173 |
| gamma-hexachlorocyclohexane | increases activity | EXP | | 6480464 | Lindane results in increased activity of CASP9 protein | CTD | PMID:22001173 |
| gamma-hexachlorocyclohexane | decreases activity | EXP | | 6480464 | Lindane results in decreased activity of CASP9 protein | CTD | PMID:19041923 |
| gedunin | increases activity | ISO | RGD:69147 | 6480464 | gedunin results in increased activity of CASP9 protein | CTD | PMID:21381696 |
| geldanamycin | multiple interactions | ISO | RGD:69147 | 6480464 | geldanamycin inhibits the reaction [Doxorubicin results in increased cleavage of CASP9 protein] | CTD | PMID:16311509 |
| geneticin | increases activity | ISO | RGD:69147 | 6480464 | antibiotic G 418 results in increased activity of CASP9 protein | CTD | PMID:15241557 |
| geneticin | multiple interactions | ISO | RGD:69147 | 6480464 | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [antibiotic G 418 results in increased activity of CASP9 protein] | CTD | PMID:15241557 |
| genistein | multiple interactions | ISO | RGD:69147 | 6480464 | [Genistein co-treated with TNFSF10 protein] results in increased activity of CASP9 protein | CTD | PMID:19497411 |
| genistein | increases activity | ISO | RGD:69147 | 6480464 | Genistein results in increased activity of CASP9 protein | CTD | PMID:20219070 |
| genistein | multiple interactions | ISO | RGD:69147 | 6480464 | Genistein promotes the reaction [arsenic trioxide results in increased activity of CASP9 protein] | CTD | PMID:20219070 |
| genistein | multiple interactions | ISO | RGD:69147 | 6480464 | Genistein inhibits the reaction [benzo(e)pyrene results in increased activity of CASP9 protein] | CTD | PMID:19959636 |
| glucose | multiple interactions | ISO | RGD:69147 | 6480464 | [Glucose deficiency co-treated with Acetylcysteine] results in increased activity of CASP9 protein; more ... | CTD | PMID:17309078 |
| glucose | increases activity | EXP | | 6480464 | Glucose results in increased activity of CASP9 | CTD | PMID:18791325 |
| glucose | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [Glucose results in increased activity of CASP9] | CTD | PMID:18791325 |
| glutathione | multiple interactions | ISO | RGD:69147 | 6480464 | Glutathione affects the reaction [SOD2 protein affects the activity of CASP9 protein] | CTD | PMID:18594523 |
| glutathione | multiple interactions | ISO | RGD:69147 | 6480464 | Glutathione inhibits the reaction [Thimerosal results in increased activity of CASP9 protein] | CTD | PMID:12140745 |
| glycochenodeoxycholic acid | increases activity | EXP | | 6480464 | Glycochenodeoxycholic Acid results in increased activity of CASP9 protein | CTD | PMID:15767249 |
| glycochenodeoxycholic acid | multiple interactions | ISO | RGD:69147 | 6480464 | Sulfasalazine inhibits the reaction [Glycochenodeoxycholic Acid results in increased activity of CASP9 protein] | CTD | PMID:16322111 |
| glycochenodeoxycholic acid | increases activity | ISO | RGD:69147 | 6480464 | Glycochenodeoxycholic Acid results in increased activity of CASP9 protein | CTD | PMID:16322111 |
| glycyrrhizinic acid | multiple interactions | EXP | | 6480464 | Glycyrrhizic Acid inhibits the reaction [Benzo(a)pyrene results in increased activity of CASP9 protein] | CTD | PMID:22051199 |
| hesperidin | multiple interactions | EXP | | 6480464 | Hesperidin inhibits the reaction [Acetaminophen results in increased expression of CASP9 protein]; more ... | CTD | PMID:22093918 |
| hexachlorobenzene | multiple interactions | EXP | | 6480464 | Hexachlorobenzene results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:19182106 |
| hexachlorobenzene | increases activity | EXP | | 6480464 | Hexachlorobenzene results in increased activity of CASP9 protein | CTD | PMID:21787832 |
| hydrogen chloride | decreases expression | ISO | RGD:69147 | 6480464 | Hydrochloric Acid results in decreased expression of CASP9 mRNA | CTD | PMID:15046208 |
| hydrogen peroxide | multiple interactions | ISO | RGD:69147 | 6480464 | Aspirin inhibits the reaction [Hydrogen Peroxide results in increased activity of CASP9 protein] | CTD | PMID:14753751 |
| hydrogen peroxide | increases cleavage | ISO | RGD:62159 | 6480464 | Hydrogen Peroxide results in increased cleavage of CASP9 protein | CTD | PMID:12626342 more ... |
| hydrogen peroxide | multiple interactions | ISO | RGD:62159 | 6480464 | PARP1 protein promotes the reaction [Hydrogen Peroxide results in increased cleavage of CASP9 protein] | CTD | PMID:20878536 |
| hydrogen peroxide | affects expression | ISO | RGD:69147 | 6480464 | Hydrogen Peroxide affects the expression of CASP9 protein | CTD | PMID:21179406 |
| hydrogen peroxide | increases cleavage | ISO | RGD:62159 | 6480464 | Hydrogen Peroxide results in increased cleavage of CASP9 protein | CTD | PMID:12626342 PMID:15876423 |
| hydrogen peroxide | increases activity | ISO | RGD:69147 | 6480464 | Hydrogen Peroxide results in increased activity of CASP9 protein | CTD | PMID:14753751 PMID:21431366 |
| hydrogen peroxide | multiple interactions | EXP | | 6480464 | 3,4-dihydro-5-methyl-1(2H)-isoquinolinone inhibits the reaction [Hydrogen Peroxide results in increased cleavage of CASP9 protein]; more ... | CTD | PMID:16505238 |
| hydrogen peroxide | multiple interactions | ISO | RGD:62159 | 6480464 | Quercetin inhibits the reaction [Hydrogen Peroxide results in increased cleavage of CASP9 protein] | CTD | PMID:15876423 |
| hydrogen peroxide | increases cleavage | ISO | RGD:62159 | 6480464 | Hydrogen Peroxide results in increased cleavage of CASP9 protein | CTD | PMID:15876423 PMID:12626342 |
| hydrogen peroxide | multiple interactions | ISO | RGD:69147 | 6480464 | Melatonin promotes the reaction [Hydrogen Peroxide results in increased activity of CASP9 protein] | CTD | PMID:21431366 |
| hydrogen peroxide | increases activity | ISO | RGD:69147 | 6480464 | Hydrogen Peroxide results in increased activity of CASP9 protein | CTD | PMID:21431366 PMID:14753751 |
| hydroquinone | increases activity | ISO | RGD:69147 | 6480464 | hydroquinone results in increased activity of CASP9 protein | CTD | PMID:15816534 |
| hydroquinone | increases activity | ISO | RGD:69147 | 6480464 | hydroquinone results in increased activity of CASP9 protein | CTD | PMID:15816534 PMID:20946948 |
| hydroquinone | increases cleavage | ISO | RGD:69147 | 6480464 | hydroquinone results in increased cleavage of CASP9 protein | CTD | PMID:15777082 |
| hydroquinone | decreases expression | ISO | RGD:69147 | 6480464 | hydroquinone results in decreased expression of CASP9 mRNA | CTD | PMID:15452088 |
| ifosfamide | multiple interactions | ISO | RGD:69147 | 6480464 | BCL2 protein inhibits the reaction [Ifosfamide results in increased activity of CASP9 protein] | CTD | PMID:11723234 |
| indole-3-methanol | increases activity | ISO | RGD:69147 | 6480464 | indole-3-carbinol results in increased activity of CASP9 protein | CTD | PMID:16082211 |
| indole-3-methanol | multiple interactions | ISO | RGD:69147 | 6480464 | indole-3-carbinol results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:20335513 |
| indomethacin | multiple interactions | ISO | RGD:69147 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the reaction [Indomethacin results in increased activity of CASP9 protein]; more ... | CTD | PMID:17341418 |
| indomethacin | multiple interactions | EXP | | 6480464 | tryptamine analog inhibits the reaction [Indomethacin results in increased activity of CASP9 protein] | CTD | PMID:22157011 |
| indomethacin | increases activity | EXP | | 6480464 | Indomethacin results in increased activity of CASP9 protein | CTD | PMID:16184425 more ... |
| indomethacin | increases activity | EXP | | 6480464 | Indomethacin results in increased activity of CASP9 protein | CTD | PMID:18375387 more ... |
| indomethacin | increases activity | EXP | | 6480464 | Indomethacin results in increased activity of CASP9 protein | CTD | PMID:16184425 more ... |
| indomethacin | increases activity | EXP | | 6480464 | Indomethacin results in increased activity of CASP9 protein | CTD | PMID:18375387 more ... |
| indomethacin | increases activity | ISO | RGD:69147 | 6480464 | Indomethacin results in increased activity of CASP9 protein | CTD | PMID:15812552 more ... |
| indomethacin | increases activity | EXP | | 6480464 | Indomethacin results in increased activity of CASP9 protein | CTD | PMID:19220725 more ... |
| indomethacin | increases activity | ISO | RGD:69147 | 6480464 | Indomethacin results in increased activity of CASP9 protein | CTD | PMID:11005569 more ... |
| indomethacin | multiple interactions | EXP | | 6480464 | Melatonin inhibits the reaction [Indomethacin results in increased activity of CASP9 protein] | CTD | PMID:19220725 |
| indomethacin | multiple interactions | EXP | | 6480464 | rebamipide inhibits the reaction [Indomethacin results in increased activity of CASP9 protein] | CTD | PMID:16184425 |
| indomethacin | multiple interactions | EXP | | 6480464 | lansoprazole inhibits the reaction [Indomethacin results in increased activity of CASP9 protein] | CTD | PMID:18375387 |
| indomethacin | increases activity | EXP | | 6480464 | Indomethacin results in increased activity of CASP9 protein | CTD | PMID:19220725 more ... |
| indomethacin | increases activity | ISO | RGD:69147 | 6480464 | Indomethacin results in increased activity of CASP9 protein | CTD | PMID:11005569 more ... |
| indomethacin | multiple interactions | ISO | RGD:69147 | 6480464 | Indomethacin results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:15804060 |
| indomethacin | multiple interactions | ISO | RGD:69147 | 6480464 | [Indomethacin results in increased activity of CASP9 protein] which results in increased susceptibility to Doxorubicin | CTD | PMID:15812552 |
| isatin | multiple interactions | ISO | RGD:69147 | 6480464 | [Copper binds to Isatin binds to 2-(2-aminoethyl)pyridine] which results in increased cleavage of CASP9 protein; more ... | CTD | PMID:17327230 |
| isoflurane | decreases expression | EXP | | 6480464 | Isoflurane results in decreased expression of CASP9 mRNA | CTD | PMID:16978161 |
| kaempferol | increases cleavage | ISO | RGD:69147 | 6480464 | kaempferol results in increased cleavage of CASP9 protein | CTD | PMID:18331776 |
| ketamine | increases activity | ISO | RGD:69147 | 6480464 | Ketamine results in increased activity of CASP9 protein | CTD | PMID:19001360 |
| ketamine | increases expression | EXP | | 6480464 | Ketamine results in increased expression of CASP9 mRNA | CTD | PMID:20080153 |
| L-ascorbic acid | multiple interactions | EXP | | 6480464 | Ascorbic Acid inhibits the reaction [Norepinephrine results in increased activity of CASP9 protein] | CTD | PMID:15158148 |
| L-ascorbic acid | multiple interactions | EXP | | 6480464 | [Vitamin E co-treated with Ascorbic Acid] inhibits the reaction [Dichlorvos results in increased activity of CASP9 protein] | CTD | PMID:16973328 |
| L-mimosine | multiple interactions | ISO | RGD:69147 | 6480464 | Mimosine results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:18058236 |
| lansoprazole | multiple interactions | EXP | | 6480464 | lansoprazole inhibits the reaction [Indomethacin results in increased activity of CASP9 protein] | CTD | PMID:18375387 |
| leuprolide | increases expression | ISO | RGD:69147 | 6480464 | Leuprolide results in increased expression of CASP9 protein | CTD | PMID:15965100 |
| lidocaine | decreases expression | ISO | RGD:69147 | 6480464 | Lidocaine results in decreased expression of CASP9 protein | CTD | PMID:20194319 |
| lipoic acid | increases activity | ISO | RGD:69147 | 6480464 | Thioctic Acid results in increased activity of CASP9 protein | CTD | PMID:16990509 |
| lipoic acid | multiple interactions | EXP | | 6480464 | Thioctic Acid inhibits the reaction [Streptozocin results in increased expression of CASP9 protein] | CTD | PMID:19951573 |
| lonidamine | multiple interactions | ISO | RGD:69147 | 6480464 | lonidamine promotes the reaction [arsenic trioxide results in increased cleavage of and results in increased activity of CASP9 protein]; more ... | CTD | PMID:21889928 |
| lonidamine | multiple interactions | ISO | RGD:69147 | 6480464 | [Curcumin co-treated with lonidamine] results in increased cleavage of CASP9 protein | CTD | PMID:20605902 |
| losartan | increases cleavage | EXP | | 6480464 | Losartan results in increased cleavage of CASP9 protein | CTD | PMID:12623880 |
| lovastatin | increases activity | ISO | RGD:69147 | 6480464 | Lovastatin results in increased activity of CASP9 protein | CTD | PMID:15705602 PMID:12933658 |
| lovastatin | increases activity | ISO | RGD:69147 | 6480464 | Lovastatin results in increased activity of CASP9 protein | CTD | PMID:12933658 PMID:15705602 |
| lovastatin | increases activity | ISO | RGD:62159 | 6480464 | Lovastatin results in increased activity of CASP9 protein | CTD | PMID:15180944 |
| luteolin | increases cleavage | ISO | RGD:69147 | 6480464 | Luteolin results in increased cleavage of CASP9 protein | CTD | PMID:18331776 PMID:19397994 |
| luteolin | increases activity | ISO | RGD:69147 | 6480464 | Luteolin results in increased activity of CASP9 protein | CTD | PMID:21601631 |
| luteolin | increases cleavage | ISO | RGD:69147 | 6480464 | Luteolin results in increased cleavage of CASP9 protein | CTD | PMID:19397994 PMID:18331776 |
| LY294002 | multiple interactions | ISO | RGD:69147 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the reaction [Indomethacin results in increased activity of CASP9 protein] | CTD | PMID:17341418 |
| LY294002 | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [NRG1 protein inhibits the reaction [Doxorubicin results in increased activity of CASP9 protein]] | CTD | PMID:19801490 |
| LY294002 | multiple interactions | ISO | RGD:69147 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Doxorubicin results in increased cleavage of CASP9 protein]; more ... | CTD | PMID:20856197 |
| LY294002 | multiple interactions | ISO | RGD:69147 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Simvastatin results in decreased activity of CASP9 protein] | CTD | PMID:12438947 |
| LY294002 | multiple interactions | ISO | RGD:69147 | 6480464 | [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with fludarabine] results in increased cleavage of CASP9 protein | CTD | PMID:15850772 |
| malathion | increases activity | ISO | RGD:62159 | 6480464 | Malathion results in increased activity of CASP9 protein | CTD | PMID:12505448 |
| malathion | multiple interactions | EXP | | 6480464 | [Vitamin E co-treated with Selenium] inhibits the reaction [Malathion results in increased expression of CASP9 mRNA] | CTD | PMID:21628957 |
| malathion | increases expression | EXP | | 6480464 | Malathion results in increased expression of CASP9 mRNA | CTD | PMID:21628957 |
| malonic acid | multiple interactions | EXP | | 6480464 | malonic acid inhibits the reaction [chelerythrine results in increased activity of CASP9 protein] | CTD | PMID:21664962 |
| maneb | multiple interactions | ISO | RGD:62159 | 6480464 | Melatonin inhibits the reaction [[Paraquat co-treated with Maneb] results in increased expression of CASP9 protein]; more ... | CTD | PMID:20964710 |
| maneb | increases activity | ISO | RGD:69147 | 6480464 | Maneb results in increased activity of CASP9 protein | CTD | PMID:22824503 |
| manganese atom | increases cleavage | EXP | | 6480464 | Manganese results in increased cleavage of CASP9 protein | CTD | PMID:16787641 |
| manganese(0) | increases cleavage | EXP | | 6480464 | Manganese results in increased cleavage of CASP9 protein | CTD | PMID:16787641 |
| manganese(II) chloride | increases cleavage | EXP | | 6480464 | manganese chloride results in increased cleavage of CASP9 protein | CTD | PMID:16787641 |
| manganese(II) chloride | multiple interactions | ISO | RGD:62159 | 6480464 | PRNP protein inhibits the reaction [manganese chloride results in increased activity of CASP9 protein] | CTD | PMID:17483122 |
| manganese(II) chloride | increases activity | ISO | RGD:62159 | 6480464 | manganese chloride results in increased activity of CASP9 protein | CTD | PMID:17483122 |
| mechlorethamine | increases activity | ISO | RGD:69147 | 6480464 | Mechlorethamine results in increased activity of CASP9 protein | CTD | PMID:16738803 |
| melamine | multiple interactions | ISO | RGD:69147 | 6480464 | 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [melamine results in increased cleavage of CASP9 protein]; more ... | CTD | PMID:22915474 |
| melamine | increases cleavage | ISO | RGD:69147 | 6480464 | melamine results in increased cleavage of CASP9 protein | CTD | PMID:22915474 |
| melatonin | multiple interactions | ISO | RGD:69147 | 6480464 | Melatonin inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased activity of CASP9 protein]; more ... | CTD | PMID:20130848 |
| melatonin | multiple interactions | ISO | RGD:62159 | 6480464 | Melatonin inhibits the reaction [[Paraquat co-treated with Maneb] results in increased expression of CASP9 protein] | CTD | PMID:20964710 |
| melatonin | increases activity | ISO | RGD:69147 | 6480464 | Melatonin results in increased activity of CASP9 protein | CTD | PMID:19012662 PMID:19552762 |
| melatonin | multiple interactions | EXP | | 6480464 | Melatonin inhibits the reaction [Indomethacin results in increased activity of CASP9 protein] | CTD | PMID:19220725 |
| melatonin | multiple interactions | ISO | RGD:69147 | 6480464 | Melatonin promotes the reaction [Hydrogen Peroxide results in increased activity of CASP9 protein] | CTD | PMID:21431366 |
| melatonin | increases activity | ISO | RGD:69147 | 6480464 | Melatonin results in increased activity of CASP9 protein | CTD | PMID:19552762 PMID:19012662 |
| menadione | multiple interactions | ISO | RGD:69147 | 6480464 | Acetylcysteine inhibits the reaction [[sodium arsenite co-treated with Vitamin K 3] results in increased activity of CASP9 protein] | CTD | PMID:19082730 |
| menadione | increases cleavage | EXP | | 6480464 | Vitamin K 3 results in increased cleavage of CASP9 protein | CTD | PMID:16310883 |
| menadione | multiple interactions | EXP | | 6480464 | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [Vitamin K 3 results in increased cleavage of CASP9 protein] | CTD | PMID:16310883 |
| mercury atom | increases expression | EXP | | 6480464 | Mercury results in increased expression of CASP9 protein | CTD | PMID:21186712 |
| mercury dichloride | increases expression | ISO | RGD:62159 | 6480464 | Mercuric Chloride results in increased expression of CASP9 protein | CTD | PMID:21373768 |
| mercury(0) | increases expression | EXP | | 6480464 | Mercury results in increased expression of CASP9 protein | CTD | PMID:21186712 |
| methapyrilene | increases expression | EXP | | 6480464 | Methapyrilene results in increased expression of CASP9 mRNA | CTD | PMID:17450226 |
| methimazole | multiple interactions | EXP | | 6480464 | Methimazole results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:17171702 |
| methoxsalen | decreases expression | ISO | RGD:69147 | 6480464 | Methoxsalen results in decreased expression of CASP9 protein | CTD | PMID:22796345 |
| methoxychlor | increases expression | EXP | | 6480464 | Methoxychlor results in increased expression of CASP9 protein | CTD | PMID:20227399 |
| methyl methanesulfonate | increases activity | ISO | RGD:62159 | 6480464 | Methyl Methanesulfonate results in increased activity of CASP9 protein | CTD | PMID:16019050 |
| methyltestosterone | multiple interactions | EXP | | 6480464 | [Gossypol co-treated with Methyltestosterone co-treated with Ethinyl Estradiol] results in increased expression of CASP9 mRNA | CTD | PMID:15451339 |
| metoprolol | increases cleavage | ISO | RGD:69147 | 6480464 | Metoprolol results in increased cleavage of CASP9 protein | CTD | PMID:19106745 |
| mevalonic acid | multiple interactions | ISO | RGD:69147 | 6480464 | Mevalonic Acid inhibits the reaction [Simvastatin results in increased cleavage of CASP9 protein] | CTD | PMID:20045437 |
| mevalonic acid | multiple interactions | EXP | | 6480464 | Mevalonic Acid inhibits the reaction [atorvastatin results in increased activity of CASP9 protein] | CTD | PMID:18339080 |
| minocycline | decreases activity | ISO | RGD:62159 | 6480464 | Minocycline results in decreased activity of CASP9 protein | CTD | PMID:12930891 |
| minocycline | decreases expression | EXP | | 6480464 | Minocycline results in decreased expression of CASP9 mRNA | CTD | PMID:14998631 |
| minocycline | multiple interactions | EXP | | 6480464 | Minocycline results in decreased expression of and results in decreased activity of CASP9 protein | CTD | PMID:14998631 |
| minocycline | multiple interactions | EXP | | 6480464 | Minocycline inhibits the reaction [HTT protein mutant form results in increased activity of CASP9 protein] | CTD | PMID:12930891 |
| mitomycin C | multiple interactions | ISO | RGD:69147 | 6480464 | Mitomycin promotes the reaction [CASP9 protein results in increased secretion of CYCS protein] | CTD | PMID:10960761 |
| mitomycin C | increases activity | ISO | RGD:69147 | 6480464 | Mitomycin results in increased activity of CASP9 protein | CTD | PMID:16186332 more ... |
| mitomycin C | increases activity | ISO | RGD:69147 | 6480464 | Mitomycin results in increased activity of CASP9 protein | CTD | PMID:17530733 more ... |
| mitomycin C | increases activity | ISO | RGD:69147 | 6480464 | Mitomycin results in increased activity of CASP9 protein | CTD | PMID:17094455 more ... |
| mitomycin C | multiple interactions | ISO | RGD:69147 | 6480464 | Mitomycin results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:12181741 |
| mitomycin C | increases activity | ISO | RGD:69147 | 6480464 | Mitomycin results in increased activity of CASP9 protein | CTD | PMID:17530733 more ... |
| mitoxantrone | increases activity | ISO | RGD:69147 | 6480464 | Mitoxantrone results in increased activity of CASP9 protein | CTD | PMID:12948851 |
| monocrotophos | increases expression | EXP | | 6480464 | Monocrotophos results in increased expression of CASP9 mRNA; more ... | CTD | PMID:20957986 |
| monocrotophos | increases expression | EXP | | 6480464 | Monocrotophos results in increased expression of CASP9 protein | CTD | PMID:21445290 |
| monocrotophos | increases expression | EXP | | 6480464 | Monocrotophos results in increased expression of CASP9 mRNA | CTD | PMID:20957986 PMID:21445290 |
| morphine | increases activity | ISO | RGD:69147 | 6480464 | Morphine results in increased activity of CASP9 protein | CTD | PMID:19292871 |
| morphine | increases expression | EXP | | 6480464 | Morphine results in increased expression of CASP9 mRNA | CTD | PMID:15183518 |
| myricetin | increases activity | ISO | RGD:69147 | 6480464 | myricetin results in increased activity of CASP9 protein | CTD | PMID:15748703 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:69147 | 6480464 | Acetylcysteine inhibits the reaction [cadmium acetate results in increased activity of CASP9 protein] | CTD | PMID:16169029 |
| N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [Chlorpyrifos results in increased activity of CASP9 protein] | CTD | PMID:22714038 |
| N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] results in increased cleavage of CASP9 protein] | CTD | PMID:22085843 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:69147 | 6480464 | Acetylcysteine inhibits the reaction [Lipopolysaccharides results in increased activity of CASP9 protein] | CTD | PMID:20848084 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:69147 | 6480464 | Acetylcysteine inhibits the reaction [cordycepin results in increased activity of CASP9 protein] | CTD | PMID:21310227 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:62159 | 6480464 | Acetylcysteine inhibits the reaction [Methylmercury Compounds results in increased expression of CASP9 mRNA] | CTD | PMID:21549813 |
| N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [arsenic trioxide results in increased activity of CASP9 protein] | CTD | PMID:21145380 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:62159 | 6480464 | Acetylcysteine inhibits the reaction [plumbagin results in increased activity of CASP9 protein] | CTD | PMID:20576514 |
| N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased activity of CASP9 protein] | CTD | PMID:18629305 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:69147 | 6480464 | Acetylcysteine affects the reaction [SOD2 protein affects the activity of CASP9 protein] | CTD | PMID:18594523 |
| N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [Norepinephrine results in increased activity of CASP9 protein] | CTD | PMID:15158148 |
| N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [Glucose results in increased activity of CASP9] | CTD | PMID:18791325 |
| N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [Cholesterol analog results in increased activity of CASP9 protein]; more ... | CTD | PMID:19477266 |
| N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [Carboplatin results in increased expression of CASP9 protein] | CTD | PMID:18483861 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:62159 | 6480464 | Acetylcysteine inhibits the reaction [Cisplatin results in increased cleavage of CASP9 protein]; more ... | CTD | PMID:21616140 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:62159 | 6480464 | Acetylcysteine inhibits the reaction [arsenic trioxide results in decreased expression of CASP9 protein]; more ... | CTD | PMID:18336854 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:69147 | 6480464 | [Glucose deficiency co-treated with Acetylcysteine] results in increased activity of CASP9 protein | CTD | PMID:17309078 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:69147 | 6480464 | Acetylcysteine inhibits the reaction [[sodium arsenite co-treated with Vitamin K 3] results in increased activity of CASP9 protein] | CTD | PMID:19082730 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:69147 | 6480464 | Acetylcysteine inhibits the reaction [Cisplatin results in increased cleavage of CASP9 protein] | CTD | PMID:15496615 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:69147 | 6480464 | Acetylcysteine inhibits the reaction [Cisplatin results in increased activity of CASP9 protein] | CTD | PMID:21166495 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:69147 | 6480464 | Acetylcysteine inhibits the reaction [[Cisplatin co-treated with FASLG protein] results in increased activity of CASP9 protein] | CTD | PMID:17574045 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:69147 | 6480464 | Acetylcysteine inhibits the reaction [arsenic trioxide results in increased activity of CASP9 protein] | CTD | PMID:19771260 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:69147 | 6480464 | Acetylcysteine inhibits the reaction [arsenic trioxide promotes the reaction [Poly I-C results in increased activity of CASP9 protein]]; more ... | CTD | PMID:21418039 |
| N-formyl-L-methionyl-L-leucyl-L-phenylalanine | multiple interactions | ISO | RGD:69147 | 6480464 | Melatonin inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased activity of CASP9 protein] | CTD | PMID:20130848 |
| N-formyl-L-methionyl-L-leucyl-L-phenylalanine | increases activity | ISO | RGD:69147 | 6480464 | N-Formylmethionine Leucyl-Phenylalanine results in increased activity of CASP9 protein | CTD | PMID:20130848 |
| N-methyl-N'-nitro-N-nitrosoguanidine | increases activity | ISO | RGD:69147 | 6480464 | Methylnitronitrosoguanidine results in increased activity of CASP9 protein | CTD | PMID:15589979 |
| N-methyl-N'-nitro-N-nitrosoguanidine | decreases expression | ISO | RGD:62159 | 6480464 | Methylnitronitrosoguanidine results in decreased expression of CASP9 protein | CTD | PMID:20434464 |
| N-methyl-N'-nitro-N-nitrosoguanidine | multiple interactions | ISO | RGD:62159 | 6480464 | Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of CASP9 protein] | CTD | PMID:20434464 |
| N-methyl-N'-nitro-N-nitrosoguanidine | increases activity | ISO | RGD:62159 | 6480464 | Methylnitronitrosoguanidine results in increased activity of CASP9 protein | CTD | PMID:16019050 |
| N-nitrosodiethylamine | increases expression | ISO | RGD:62159 | 6480464 | Diethylnitrosamine results in increased expression of CASP9 mRNA | CTD | PMID:18691550 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [ferric nitrilotriacetate co-treated with Diethylnitrosamine] results in decreased cleavage of and results in decreased expression of CASP9 protein; more ... | CTD | PMID:21907755 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | morin inhibits the reaction [Diethylnitrosamine results in decreased expression of CASP9 protein] | CTD | PMID:19931519 |
| N-nitrosodiethylamine | decreases expression | EXP | | 6480464 | Diethylnitrosamine results in decreased expression of CASP9 protein | CTD | PMID:19931519 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:62159 | 6480464 | MAPK14 protein inhibits the reaction [Diethylnitrosamine results in increased expression of CASP9 mRNA] | CTD | PMID:18691550 |
| N-tosyl-L-phenylalanyl chloromethyl ketone | multiple interactions | ISO | RGD:69147 | 6480464 | Tosylphenylalanyl Chloromethyl Ketone results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:19679660 |
| naphthalene | multiple interactions | ISO | RGD:69147 | 6480464 | [naphthalene binds to pyrrolo(2,1-c)(1,4)benzodiazepine] which results in increased expression of CASP9 protein | CTD | PMID:21732540 |
| naringin | increases expression | ISO | RGD:69147 | 6480464 | naringin results in increased expression of CASP9 mRNA | CTD | PMID:22847135 |
| nickel atom | multiple interactions | ISO | RGD:69147 | 6480464 | [Quercetin analog co-treated with Nickel] results in increased activity of CASP9 protein | CTD | PMID:20577783 |
| nickel dichloride | increases activity | EXP | | 6480464 | nickel chloride results in increased activity of CASP9 protein | CTD | PMID:21843586 |
| nickel dichloride | multiple interactions | EXP | | 6480464 | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [nickel chloride results in increased activity of CASP9 protein] | CTD | PMID:21843586 |
| nicotinamide | multiple interactions | EXP | | 6480464 | Niacinamide inhibits the reaction [Hydrogen Peroxide results in increased cleavage of CASP9 protein] | CTD | PMID:16505238 |
| nimesulide | multiple interactions | ISO | RGD:69147 | 6480464 | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [nimesulide results in increased cleavage of and results in increased activity of CASP9 protein] | CTD | PMID:19360361 |
| nimesulide | increases activity | EXP | | 6480464 | nimesulide results in increased activity of CASP9 protein | CTD | PMID:19772912 |
| nimesulide | multiple interactions | ISO | RGD:69147 | 6480464 | nimesulide inhibits the reaction [Etoposide results in increased cleavage of and results in increased activity of CASP9 protein] | CTD | PMID:21745461 |
| nitric oxide | decreases activity | ISO | RGD:62159 | 6480464 | Nitric Oxide results in decreased activity of CASP9 protein | CTD | PMID:14634119 |
| nitric oxide | increases activity | ISO | RGD:69147 | 6480464 | Nitric Oxide results in increased activity of CASP9 protein | CTD | PMID:15126337 |
| nitroprusside | decreases activity | ISO | RGD:69147 | 6480464 | Nitroprusside results in decreased activity of CASP9 protein | CTD | PMID:22543296 |
| nitroprusside | multiple interactions | ISO | RGD:69147 | 6480464 | Ursodeoxycholic Acid inhibits the reaction [Nitroprusside results in increased activity of CASP9 protein] | CTD | PMID:22178905 |
| nitroprusside | increases activity | ISO | RGD:69147 | 6480464 | Nitroprusside results in increased activity of CASP9 protein | CTD | PMID:22178905 |
| ochratoxin A | multiple interactions | ISO | RGD:69147 | 6480464 | ochratoxin A results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:19367635 |
| ochratoxin A | increases cleavage | ISO | RGD:69147 | 6480464 | ochratoxin A results in increased cleavage of CASP9 protein | CTD | PMID:20549612 |
| ochratoxin A | increases activity | ISO | RGD:69147 | 6480464 | ochratoxin A results in increased activity of CASP9 protein | CTD | PMID:15056805 |
| ochratoxin A | decreases expression | ISO | RGD:69147 | 6480464 | ochratoxin A results in decreased expression of CASP9 mRNA | CTD | PMID:17316727 |
| ochratoxin A | increases activity | EXP | | 6480464 | ochratoxin A results in increased activity of CASP9 protein | CTD | PMID:19562491 |
| okadaic acid | multiple interactions | ISO | RGD:69147 | 6480464 | Okadaic Acid results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:19084044 |
| oleic acid | multiple interactions | EXP | | 6480464 | IRS2 inhibits the reaction [Oleic Acid results in increased cleavage of CASP9 protein] | CTD | PMID:14604813 |
| oleic acid | increases cleavage | EXP | | 6480464 | Oleic Acid results in increased cleavage of CASP9 protein | CTD | PMID:14604813 |
| oroxylin A | decreases expression | ISO | RGD:69147 | 6480464 | 5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one results in decreased expression of CASP9 protein | CTD | PMID:19135124 |
| ozone | increases cleavage | EXP | | 6480464 | Ozone results in increased cleavage of CASP9 protein | CTD | PMID:22727909 |
| paclitaxel | multiple interactions | ISO | RGD:69147 | 6480464 | [6-((3-chloro)anilino)-2-(isopropyl-2-hydroxyethylamino)-9-isopropylpurine co-treated with Paclitaxel] results in increased activity of CASP9 protein; more ... | CTD | PMID:16170024 |
| paclitaxel | multiple interactions | ISO | RGD:69147 | 6480464 | [benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP9 protein] affects the reaction [SOD2 protein results in decreased susceptibility to Paclitaxel]; more ... | CTD | PMID:18594523 |
| paclitaxel | multiple interactions | ISO | RGD:62159 | 6480464 | CASP9 protein affects the reaction [Paclitaxel results in increased activity of and results in increased cleavage of CASP3 protein] | CTD | PMID:17652622 |
| paclitaxel | multiple interactions | ISO | RGD:69147 | 6480464 | [Tretinoin co-treated with Paclitaxel] results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:17701358 |
| paclitaxel | multiple interactions | ISO | RGD:69147 | 6480464 | [Sirolimus co-treated with Paclitaxel] results in increased cleavage of CASP9 protein | CTD | PMID:15753396 |
| paclitaxel | multiple interactions | ISO | RGD:69147 | 6480464 | [resveratrol co-treated with Paclitaxel] results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:14749477 |
| paclitaxel | increases expression | ISO | RGD:69147 | 6480464 | Paclitaxel results in increased expression of CASP9 protein | CTD | PMID:15907983 |
| paclitaxel | increases expression | ISO | RGD:69147 | 6480464 | Paclitaxel results in increased expression of CASP9 mRNA | CTD | PMID:18058816 |
| paclitaxel | increases activity | ISO | RGD:69147 | 6480464 | Paclitaxel results in increased activity of CASP9 protein | CTD | PMID:18098270 |
| paclitaxel | multiple interactions | ISO | RGD:69147 | 6480464 | [Doxorubicin co-treated with Paclitaxel] results in increased activity of CASP9 protein; more ... | CTD | PMID:16168113 |
| paclitaxel | affects response to substance | ISO | RGD:69147 | 6480464 | CASP9 protein affects the susceptibility to Paclitaxel | CTD | PMID:17652622 |
| paracetamol | increases cleavage | EXP | | 6480464 | Acetaminophen results in increased cleavage of CASP9 protein | CTD | PMID:19922764 |
| paracetamol | multiple interactions | EXP | | 6480464 | Hesperidin inhibits the reaction [Acetaminophen results in increased expression of CASP9 mRNA]; more ... | CTD | PMID:22093918 |
| paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of CASP9 protein | CTD | PMID:22093918 |
| paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of CASP9 mRNA | CTD | PMID:21807079 PMID:22093918 |
| paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of CASP9 mRNA | CTD | PMID:21807079 |
| paracetamol | decreases activity | EXP | | 6480464 | Acetaminophen results in decreased activity of CASP9 | CTD | PMID:20079345 |
| paracetamol | increases cleavage | ISO | RGD:62159 | 6480464 | Acetaminophen results in increased cleavage of CASP9 protein | CTD | PMID:14747384 |
| paracetamol | multiple interactions | ISO | RGD:62159 | 6480464 | manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Acetaminophen results in increased activity of CASP9 protein] | CTD | PMID:11343246 |
| paracetamol | increases activity | ISO | RGD:62159 | 6480464 | Acetaminophen results in increased activity of CASP9 protein | CTD | PMID:11343246 |
| paracetamol | affects expression | ISO | RGD:62159 | 6480464 | Acetaminophen affects the expression of CASP9 mRNA | CTD | PMID:17562736 |
| paracetamol | increases activity | ISO | RGD:69147 | 6480464 | Acetaminophen results in increased activity of CASP9 | CTD | PMID:12005112 |
| paraquat | increases expression | ISO | RGD:69147 | 6480464 | Paraquat results in increased expression of CASP9 mRNA alternative form | CTD | PMID:17064354 |
| paraquat | increases activity | ISO | RGD:69147 | 6480464 | Paraquat results in increased activity of CASP9 protein | CTD | PMID:18253895 |
| paraquat | decreases expression | ISO | RGD:69147 | 6480464 | Paraquat results in decreased expression of CASP9 mRNA | CTD | PMID:18836921 |
| paraquat | multiple interactions | ISO | RGD:69147 | 6480464 | PTGDS mutant form promotes the reaction [Paraquat results in increased cleavage of CASP9 protein]; more ... | CTD | PMID:22043816 |
| paraquat | multiple interactions | ISO | RGD:62159 | 6480464 | [Paraquat co-treated with Maneb] results in increased expression of CASP9 protein; more ... | CTD | PMID:20964710 |
| paraquat | increases cleavage | ISO | RGD:69147 | 6480464 | Paraquat results in increased cleavage of CASP9 protein | CTD | PMID:22043816 |
| pentetic acid | increases activity | ISO | RGD:69147 | 6480464 | Pentetic Acid results in increased activity of CASP9 protein | CTD | PMID:17169355 |
| perfluorooctane-1-sulfonic acid | increases expression | ISO | RGD:69147 | 6480464 | perfluorooctane sulfonic acid results in increased expression of CASP9 mRNA | CTD | PMID:19468714 |
| perfluorooctane-1-sulfonic acid | increases expression | ISO | RGD:62159 | 6480464 | perfluorooctane sulfonic acid results in increased expression of CASP9 mRNA | CTD | PMID:21115943 |
| perfluorooctanoic acid | increases expression | ISO | RGD:69147 | 6480464 | perfluorooctanoic acid results in increased expression of CASP9 mRNA | CTD | PMID:19468714 |
| peroxynitrous acid | increases expression | EXP | | 6480464 | Peroxynitrous Acid results in increased expression of CASP9 mRNA | CTD | PMID:20869986 |
| peroxynitrous acid | multiple interactions | EXP | | 6480464 | Curcumin inhibits the reaction [Peroxynitrous Acid results in increased cleavage of and results in increased activity of CASP9 protein]; more ... | CTD | PMID:20869986 |
| phenethyl isothiocyanate | increases activity | ISO | RGD:69147 | 6480464 | phenethyl isothiocyanate results in increased activity of CASP9 protein | CTD | PMID:16054126 |
| phloroglucinol | increases cleavage | ISO | RGD:69147 | 6480464 | Phloroglucinol metabolite results in increased cleavage of CASP9 protein | CTD | PMID:22796323 |
| phorate | increases expression | EXP | | 6480464 | Phorate results in increased expression of CASP9 protein; more ... | CTD | PMID:22197610 |
| phorbol 12,13-dibutanoate | increases cleavage | ISO | RGD:62159 | 6480464 | Phorbol 12,13-Dibutyrate results in increased cleavage of CASP9 protein | CTD | PMID:12626342 |
| phorbol 12,13-dibutanoate | multiple interactions | ISO | RGD:62159 | 6480464 | rottlerin inhibits the reaction [Phorbol 12,13-Dibutyrate results in increased cleavage of CASP9 protein] | CTD | PMID:12626342 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:69147 | 6480464 | [Glucose deficiency co-treated with Tetradecanoylphorbol Acetate] results in increased activity of CASP9 protein | CTD | PMID:17309078 |
| phytosphingosine | multiple interactions | ISO | RGD:69147 | 6480464 | 3,4-dihydro-5-(4-(1-piperidinyl)butoxy)-1(2H)-isoquinolinone inhibits the reaction [[arsenic trioxide co-treated with phytosphingosine] results in increased activity of CASP9 protein]; more ... | CTD | PMID:17237268 |
| pirinixic acid | multiple interactions | ISO | RGD:62159 | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of CASP9 mRNA | CTD | PMID:19710929 |
| pirinixic acid | increases expression | ISO | RGD:62159 | 6480464 | pirinixic acid results in increased expression of CASP9 mRNA | CTD | PMID:17426115 |
| plumbagin | multiple interactions | ISO | RGD:62159 | 6480464 | Acetylcysteine inhibits the reaction [plumbagin results in increased activity of CASP9 protein] | CTD | PMID:20576514 |
| plumbagin | increases activity | ISO | RGD:62159 | 6480464 | plumbagin results in increased activity of CASP9 protein | CTD | PMID:20576514 |
| pravastatin | multiple interactions | EXP | | 6480464 | Pravastatin inhibits the reaction [Carboplatin results in increased expression of CASP9 protein] | CTD | PMID:18483861 |
| propiconazole | decreases expression | ISO | RGD:62159 | 6480464 | propiconazole results in decreased expression of CASP9 mRNA | CTD | PMID:21278054 |
| propofol | decreases cleavage | EXP | | 6480464 | Propofol results in decreased cleavage of CASP9 protein | CTD | PMID:21468576 |
| propofol | increases activity | ISO | RGD:62159 | 6480464 | Propofol results in increased activity of CASP9 protein | CTD | PMID:21786383 |
| propranolol | increases cleavage | ISO | RGD:69147 | 6480464 | Propranolol results in increased cleavage of CASP9 protein | CTD | PMID:19106745 |
| pterostilbene | increases expression | ISO | RGD:69147 | 6480464 | pterostilbene results in increased expression of CASP9 protein | CTD | PMID:20152895 |
| pterostilbene | increases cleavage | ISO | RGD:62159 | 6480464 | pterostilbene results in increased cleavage of CASP9 protein | CTD | PMID:20681671 |
| puromycin | increases activity | ISO | RGD:62159 | 6480464 | Puromycin results in increased activity of CASP9 protein | CTD | PMID:14502240 |
| putrescine | increases expression | EXP | | 6480464 | Putrescine results in increased expression of CASP9 protein | CTD | PMID:17606387 |
| pyrimethamine | increases activity | ISO | RGD:69147 | 6480464 | Pyrimethamine results in increased activity of CASP9 protein | CTD | PMID:18593930 |
| pyrogallol | increases expression | ISO | RGD:62159 | 6480464 | Pyrogallol results in increased expression of CASP9 mRNA | CTD | PMID:20362636 |
| quercetin | multiple interactions | ISO | RGD:69147 | 6480464 | Quercetin inhibits the reaction [5,6-dihydro-5-(1-piperidinyl)methyl-3-(3-pyridil)-4H-1,2,4-oxa-diazine inhibits the reaction [Oxygen deficiency results in increased activity of CASP9 protein]]; more ... | CTD | PMID:15583868 |
| quercetin | multiple interactions | ISO | RGD:69147 | 6480464 | MCL1 protein inhibits the reaction [Quercetin results in increased activity of CASP9 protein] | CTD | PMID:21138867 |
| quercetin | decreases expression | EXP | | 6480464 | Quercetin results in decreased expression of CASP9 mRNA | CTD | PMID:23281070 |
| quercetin | multiple interactions | EXP | | 6480464 | Quercetin inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in increased expression of CASP9 mRNA] | CTD | PMID:23281070 |
| quercetin | increases activity | ISO | RGD:69147 | 6480464 | Quercetin results in increased activity of CASP9 protein | CTD | PMID:17234771 PMID:21138867 |
| quercetin | increases cleavage | ISO | RGD:69147 | 6480464 | Quercetin results in increased cleavage of CASP9 protein | CTD | PMID:18331776 more ... |
| quercetin | multiple interactions | ISO | RGD:69147 | 6480464 | [Quercetin analog co-treated with Nickel] results in increased activity of CASP9 protein | CTD | PMID:20577783 |
| quercetin | increases cleavage | ISO | RGD:69147 | 6480464 | Quercetin results in increased cleavage of CASP9 protein | CTD | PMID:18787224 more ... |
| quercetin | increases cleavage | ISO | RGD:69147 | 6480464 | Quercetin results in increased cleavage of CASP9 protein | CTD | PMID:18787224 more ... |
| quercetin | increases cleavage | ISO | RGD:69147 | 6480464 | Quercetin results in increased cleavage of CASP9 protein | CTD | PMID:19397994 more ... |
| quercetin | multiple interactions | ISO | RGD:62159 | 6480464 | Quercetin inhibits the reaction [Hydrogen Peroxide results in increased cleavage of CASP9 protein] | CTD | PMID:15876423 |
| quercetin | increases cleavage | ISO | RGD:69147 | 6480464 | Quercetin results in increased cleavage of CASP9 protein | CTD | PMID:18331776 more ... |
| quercetin | increases activity | ISO | RGD:69147 | 6480464 | Quercetin results in increased activity of CASP9 protein | CTD | PMID:17234771 |
| quercetin | multiple interactions | ISO | RGD:69147 | 6480464 | Quercetin promotes the reaction [TNFSF10 protein results in increased activity of CASP9 protein] | CTD | PMID:18377872 |
| ranitidine | multiple interactions | ISO | RGD:69147 | 6480464 | Ranitidine inhibits the reaction [Rotenone results in increased cleavage of CASP9 protein] | CTD | PMID:19723537 |
| resveratrol | decreases activity | ISO | RGD:69147 | 6480464 | resveratrol results in decreased activity of CASP9 protein | CTD | PMID:21505870 |
| resveratrol | increases cleavage | ISO | RGD:69147 | 6480464 | resveratrol results in increased cleavage of CASP9 protein | CTD | PMID:18347188 PMID:23152798 |
| resveratrol | increases cleavage | ISO | RGD:69147 | 6480464 | resveratrol results in increased cleavage of CASP9 protein | CTD | PMID:18347188 |
| resveratrol | multiple interactions | ISO | RGD:69147 | 6480464 | resveratrol inhibits the reaction [benzo(e)pyrene results in increased activity of CASP9 protein] | CTD | PMID:19959636 |
| resveratrol | multiple interactions | ISO | RGD:62159 | 6480464 | resveratrol results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:16675471 PMID:18791811 |
| resveratrol | increases cleavage | ISO | RGD:62159 | 6480464 | resveratrol results in increased cleavage of CASP9 protein | CTD | PMID:17872969 PMID:18201729 |
| resveratrol | decreases activity | ISO | RGD:62159 | 6480464 | resveratrol results in decreased activity of CASP9 protein | CTD | PMID:20940732 |
| resveratrol | multiple interactions | ISO | RGD:69147 | 6480464 | sirtinol inhibits the reaction [resveratrol results in increased activity of CASP9 protein] | CTD | PMID:20697895 |
| resveratrol | increases activity | ISO | RGD:69147 | 6480464 | resveratrol results in increased activity of CASP9 protein | CTD | PMID:15827328 more ... |
| resveratrol | multiple interactions | ISO | RGD:69147 | 6480464 | resveratrol results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:16617056 PMID:17636462 |
| resveratrol | increases cleavage | ISO | RGD:62159 | 6480464 | resveratrol results in increased cleavage of CASP9 protein | CTD | PMID:17872969 |
| resveratrol | multiple interactions | ISO | RGD:69147 | 6480464 | resveratrol results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:17636462 PMID:16617056 |
| resveratrol | multiple interactions | ISO | RGD:62159 | 6480464 | resveratrol results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:16675471 |
| resveratrol | multiple interactions | ISO | RGD:62159 | 6480464 | resveratrol inhibits the reaction [4-hydroxy-2-nonenal results in increased activity of CASP9 protein] | CTD | PMID:16322078 |
| resveratrol | increases activity | ISO | RGD:69147 | 6480464 | resveratrol results in increased activity of CASP9 protein | CTD | PMID:17050787 |
| resveratrol | multiple interactions | ISO | RGD:69147 | 6480464 | resveratrol promotes the reaction [TNFSF10 protein results in increased cleavage of CASP9 protein] | CTD | PMID:17823925 |
| resveratrol | multiple interactions | ISO | RGD:69147 | 6480464 | [resveratrol co-treated with Paclitaxel] results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:14749477 |
| resveratrol | multiple interactions | ISO | RGD:69147 | 6480464 | [resveratrol co-treated with TNFSF10 protein] results in increased activity of CASP9 protein | CTD | PMID:15763656 |
| resveratrol | multiple interactions | ISO | RGD:69147 | 6480464 | resveratrol results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:12902349 more ... |
| resveratrol | increases activity | ISO | RGD:69147 | 6480464 | resveratrol results in increased activity of CASP9 protein | CTD | PMID:11406544 more ... |
| resveratrol | multiple interactions | ISO | RGD:69147 | 6480464 | resveratrol inhibits the reaction [MFGE8 protein results in increased activity of CASP9 protein] | CTD | PMID:21505870 |
| resveratrol | multiple interactions | ISO | RGD:69147 | 6480464 | resveratrol promotes the reaction [Tobacco Smoke Pollution results in increased activity of CASP9 protein] | CTD | PMID:20060927 |
| resveratrol | decreases activity | EXP | | 6480464 | resveratrol results in decreased activity of CASP9 protein | CTD | PMID:20861279 |
| resveratrol | multiple interactions | ISO | RGD:69147 | 6480464 | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [[resveratrol results in increased activity of CASP8 protein] which results in increased activity of CASP9 protein] | CTD | PMID:19423619 |
| resveratrol | increases activity | ISO | RGD:69147 | 6480464 | [resveratrol results in increased activity of CASP8 protein] which results in increased activity of CASP9 protein | CTD | PMID:19423619 |
| riboflavin | increases activity | ISO | RGD:62159 | 6480464 | Riboflavin analog results in increased activity of CASP9 protein | CTD | PMID:20688149 |
| Ro 31-8220 | multiple interactions | EXP | | 6480464 | Ro 31-8220 inhibits the reaction [Lindane results in increased activity of CASP9 protein] | CTD | PMID:22001173 |
| romidepsin | multiple interactions | ISO | RGD:69147 | 6480464 | bortezomib promotes the reaction [romidepsin results in increased cleavage of CASP9 protein] | CTD | PMID:18223231 |
| romidepsin | increases cleavage | ISO | RGD:69147 | 6480464 | romidepsin results in increased cleavage of CASP9 protein | CTD | PMID:18223231 |
| ropinirole | multiple interactions | ISO | RGD:69147 | 6480464 | ropinirole inhibits the reaction [Rotenone results in increased cleavage of CASP9 protein] | CTD | PMID:18242171 |
| rosiglitazone | increases activity | ISO | RGD:69147 | 6480464 | rosiglitazone results in increased activity of CASP9 protein | CTD | PMID:17506947 |
| rotenone | multiple interactions | ISO | RGD:69147 | 6480464 | ropinirole inhibits the reaction [Rotenone results in increased cleavage of CASP9 protein] | CTD | PMID:18242171 |
| rotenone | increases cleavage | ISO | RGD:69147 | 6480464 | Rotenone results in increased cleavage of CASP9 protein | CTD | PMID:18242171 more ... |
| rotenone | multiple interactions | ISO | RGD:69147 | 6480464 | Ranitidine inhibits the reaction [Rotenone results in increased cleavage of CASP9 protein] | CTD | PMID:19723537 |
| rotenone | multiple interactions | EXP | | 6480464 | Rotenone inhibits the reaction [chelerythrine results in increased activity of CASP9 protein] | CTD | PMID:21664962 |
| rotenone | increases cleavage | ISO | RGD:69147 | 6480464 | Rotenone results in increased cleavage of CASP9 protein | CTD | PMID:18242171 PMID:19539006 |
| rotenone | multiple interactions | ISO | RGD:69147 | 6480464 | Tranexamic Acid inhibits the reaction [Rotenone results in increased cleavage of CASP9 protein] | CTD | PMID:19539006 |
| rotenone | increases cleavage | ISO | RGD:69147 | 6480464 | Rotenone results in increased cleavage of CASP9 protein | CTD | PMID:19539006 PMID:18242171 |
| rotenone | increases cleavage | ISO | RGD:69147 | 6480464 | Rotenone results in increased cleavage of CASP9 protein | CTD | PMID:18242171 |
| rotenone | increases activity | ISO | RGD:69147 | 6480464 | Rotenone results in increased activity of CASP9 protein | CTD | PMID:16917840 |
| rotenone | multiple interactions | ISO | RGD:69147 | 6480464 | 3-Hydroxybutyric Acid inhibits the reaction [Rotenone results in increased activity of CASP9 protein] | CTD | PMID:16917840 |
| ruthenium atom | multiple interactions | ISO | RGD:69147 | 6480464 | Ruthenium results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:17210701 |
| S-(1,2-dichlorovinyl)-L-cysteine | increases cleavage | ISO | RGD:69147 | 6480464 | S-(1,2-dichlorovinyl)cysteine results in increased cleavage of CASP9 protein | CTD | PMID:15967204 |
| sanguinarine | decreases expression | ISO | RGD:69147 | 6480464 | sanguinarine results in decreased expression of CASP9 protein alternative form | CTD | PMID:19135517 |
| sanguinarine | increases activity | ISO | RGD:69147 | 6480464 | sanguinarine results in increased activity of CASP9 protein | CTD | PMID:19346183 PMID:22215411 |
| sappanchalcone | increases activity | ISO | RGD:69147 | 6480464 | sappanchalcone results in increased activity of CASP9 protein | CTD | PMID:21963806 |
| saquinavir | increases cleavage | ISO | RGD:69147 | 6480464 | Saquinavir results in increased cleavage of CASP9 protein | CTD | PMID:19147209 |
| selenium atom | multiple interactions | ISO | RGD:69147 | 6480464 | [Doxorubicin co-treated with Selenium] results in increased cleavage of and results in increased activity of CASP9 protein; more ... | CTD | PMID:17339365 |
| selenium atom | multiple interactions | EXP | | 6480464 | [Vitamin E co-treated with Selenium] inhibits the reaction [Malathion results in increased expression of CASP9 mRNA] | CTD | PMID:21628957 |
| selenium atom | decreases activity | ISO | RGD:62159 | 6480464 | Selenium results in decreased activity of CASP9 protein | CTD | PMID:17997286 |
| sildenafil | affects response to substance | ISO | RGD:69147 | 6480464 | CASP9 protein affects the susceptibility to sildenafil | CTD | PMID:20884855 |
| sildenafil | multiple interactions | ISO | RGD:69147 | 6480464 | CASP9 protein mutant form inhibits the reaction [sildenafil results in increased activity of Doxorubicin]; more ... | CTD | PMID:20884855 |
| silibinin | multiple interactions | ISO | RGD:69147 | 6480464 | Caffeine inhibits the reaction [silybin results in increased cleavage of and results in increased activity of CASP9 protein]; more ... | CTD | PMID:16777994 |
| simvastatin | multiple interactions | ISO | RGD:69147 | 6480464 | Simvastatin results in increased cleavage of and results in increased activity of CASP9 protein; more ... | CTD | PMID:20045437 |
| simvastatin | multiple interactions | ISO | RGD:69147 | 6480464 | Simvastatin results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:19253821 more ... |
| simvastatin | multiple interactions | ISO | RGD:69147 | 6480464 | Simvastatin results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:20045437 PMID:19253821 |
| simvastatin | multiple interactions | ISO | RGD:69147 | 6480464 | Simvastatin results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:19253821 PMID:20045437 |
| simvastatin | increases activity | ISO | RGD:69147 | 6480464 | Simvastatin results in increased activity of CASP9 protein | CTD | PMID:15705602 PMID:16470222 |
| simvastatin | decreases activity | ISO | RGD:69147 | 6480464 | Simvastatin results in decreased activity of CASP9 protein | CTD | PMID:12438947 |
| simvastatin | multiple interactions | ISO | RGD:69147 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Simvastatin results in decreased activity of CASP9 protein] | CTD | PMID:12438947 |
| simvastatin | increases cleavage | ISO | RGD:69147 | 6480464 | Simvastatin results in increased cleavage of CASP9 protein | CTD | PMID:12962723 |
| simvastatin | increases activity | ISO | RGD:69147 | 6480464 | Simvastatin results in increased activity of CASP9 protein | CTD | PMID:16470222 PMID:15705602 |
| sirolimus | multiple interactions | ISO | RGD:69147 | 6480464 | [17-(allylamino)-17-demethoxygeldanamycin co-treated with Sirolimus] results in increased cleavage of CASP9 protein; more ... | CTD | PMID:17121904 |
| sirolimus | multiple interactions | EXP | | 6480464 | Sirolimus inhibits the reaction [Staurosporine results in increased cleavage of CASP9 protein] | CTD | PMID:16497721 |
| sirolimus | decreases activity | ISO | RGD:62159 | 6480464 | Sirolimus results in decreased activity of CASP9 protein | CTD | PMID:18097008 |
| sirolimus | multiple interactions | ISO | RGD:69147 | 6480464 | Sirolimus promotes the reaction [Cisplatin results in increased cleavage of CASP9 protein] | CTD | PMID:18058806 |
| sirolimus | multiple interactions | ISO | RGD:69147 | 6480464 | [Sirolimus co-treated with Paclitaxel] results in increased cleavage of CASP9 protein | CTD | PMID:15753396 |
| sirolimus | multiple interactions | ISO | RGD:69147 | 6480464 | [Curcumin co-treated with Sirolimus] results in increased activity of CASP9 protein | CTD | PMID:19373661 |
| sirolimus | multiple interactions | ISO | RGD:69147 | 6480464 | [7-hydroxystaurosporine co-treated with Sirolimus] results in increased cleavage of CASP9 protein | CTD | PMID:15767555 |
| sirolimus | multiple interactions | ISO | RGD:69147 | 6480464 | [Sirolimus co-treated with Cisplatin] results in increased activity of CASP9 protein | CTD | PMID:20138251 |
| sodium dichromate | increases activity | ISO | RGD:62159 | 6480464 | sodium bichromate results in increased activity of CASP9 protein | CTD | PMID:20298709 |
| sodium dichromate | multiple interactions | ISO | RGD:62159 | 6480464 | TRP53 mutant form inhibits the reaction [sodium bichromate results in increased activity of CASP9 protein]; more ... | CTD | PMID:20298709 |
| sodium fluoride | multiple interactions | ISO | RGD:69147 | 6480464 | Sodium Fluoride results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:21708216 |
| sodium fluoride | increases expression | EXP | | 6480464 | Sodium Fluoride results in increased expression of CASP9 mRNA | CTD | PMID:19009284 |
| sodium fluoride | increases activity | EXP | | 6480464 | Sodium Fluoride results in increased activity of CASP9 protein | CTD | PMID:18696052 |
| spermine | multiple interactions | ISO | RGD:62159 | 6480464 | Spermine inhibits the reaction [Dexamethasone results in increased activity of CASP9 protein] | CTD | PMID:11399061 |
| spermine | decreases expression | EXP | | 6480464 | Spermine results in decreased expression of CASP9 protein | CTD | PMID:17606387 |
| spironolactone | multiple interactions | EXP | | 6480464 | Spironolactone inhibits the reaction [Testosterone inhibits the reaction [Sorbitol results in increased activity of CASP9 protein]] | CTD | PMID:20609311 |
| staurosporine | multiple interactions | ISO | RGD:69147 | 6480464 | Staurosporine results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:16007152 |
| staurosporine | increases activity | ISO | RGD:69147 | 6480464 | Staurosporine results in increased activity of CASP9 protein | CTD | PMID:19352495 PMID:20338155 |
| staurosporine | increases activity | ISO | RGD:69147 | 6480464 | Staurosporine results in increased activity of CASP9 protein | CTD | PMID:20338155 |
| staurosporine | multiple interactions | ISO | RGD:69147 | 6480464 | ACHE protein affects the susceptibility to [Staurosporine results in increased activity of CASP9 protein] | CTD | PMID:20338155 |
| staurosporine | multiple interactions | EXP | | 6480464 | 3-methyladenine promotes the reaction [Staurosporine results in increased cleavage of CASP9 protein]; more ... | CTD | PMID:16497721 |
| streptozocin | multiple interactions | EXP | | 6480464 | Streptozocin results in increased expression of and results in increased cleavage of CASP9 protein | CTD | PMID:15976052 |
| streptozocin | increases expression | EXP | | 6480464 | Streptozocin results in increased expression of CASP9 protein | CTD | PMID:19951573 |
| streptozocin | multiple interactions | EXP | | 6480464 | Thioctic Acid inhibits the reaction [Streptozocin results in increased expression of CASP9 protein] | CTD | PMID:19951573 |
| styrene | increases activity | EXP | | 6480464 | Styrene results in increased activity of CASP9 protein | CTD | PMID:17420221 |
| sulfasalazine | multiple interactions | ISO | RGD:69147 | 6480464 | Sulfasalazine inhibits the reaction [Glycochenodeoxycholic Acid results in increased activity of CASP9 protein] | CTD | PMID:16322111 |
| sulfasalazine | increases cleavage | ISO | RGD:69147 | 6480464 | Sulfasalazine results in increased cleavage of CASP9 protein | CTD | PMID:19859796 |
| sulforaphane | multiple interactions | ISO | RGD:69147 | 6480464 | sulforafan inhibits the reaction [Oxidopamine results in increased activity of CASP9 protein] | CTD | PMID:19780897 |
| sulfur dioxide | increases expression | EXP | | 6480464 | Sulfur Dioxide results in increased expression of CASP9 mRNA | CTD | PMID:19621461 |
| sulfur dioxide | multiple interactions | EXP | | 6480464 | Sulfur Dioxide results in increased expression of and results in increased activity of CASP9 protein | CTD | PMID:19621461 |
| sulindac | multiple interactions | ISO | RGD:69147 | 6480464 | [Sulindac co-treated with arsenic trioxide] results in increased activity of CASP9 protein | CTD | PMID:18281123 |
| sulindac | increases expression | ISO | RGD:69147 | 6480464 | [Sulindac results in increased expression of IL24 protein] which results in increased expression of CASP9 protein | CTD | PMID:15713900 |
| sulindac | increases activity | ISO | RGD:69147 | 6480464 | Sulindac results in increased activity of CASP9 protein | CTD | PMID:15713900 |
| surfactin | multiple interactions | ISO | RGD:69147 | 6480464 | surfactin peptide results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:19954742 |
| surfactin C | multiple interactions | ISO | RGD:69147 | 6480464 | surfactin peptide results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:19954742 |
| tacrolimus hydrate | multiple interactions | ISO | RGD:69147 | 6480464 | Tacrolimus inhibits the reaction [FAS protein results in increased activity of CASP9 protein] | CTD | PMID:15548389 |
| tamibarotene | increases expression | ISO | RGD:69147 | 6480464 | Am 80 results in increased expression of CASP9 mRNA; more ... | CTD | PMID:15498508 |
| tamoxifen | increases cleavage | ISO | RGD:69147 | 6480464 | Tamoxifen results in increased cleavage of CASP9 protein | CTD | PMID:17767197 |
| tamoxifen | multiple interactions | ISO | RGD:69147 | 6480464 | [Tamoxifen co-treated with TNFSF10 protein] results in increased cleavage of CASP9 protein | CTD | PMID:17767197 |
| tamoxifen | increases activity | ISO | RGD:69147 | 6480464 | Tamoxifen analog results in increased activity of CASP9 protein; more ... | CTD | PMID:14990993 |
| tamoxifen | multiple interactions | ISO | RGD:69147 | 6480464 | [[methylselenic acid co-treated with Tamoxifen] results in increased cleavage of CASP9 protein] which results in increased cleavage of CASP8 protein | CTD | PMID:18790785 |
| tamoxifen | multiple interactions | ISO | RGD:69147 | 6480464 | AKT1 protein inhibits the reaction [Tamoxifen analog results in increased activity of CASP9 protein]; more ... | CTD | PMID:14990993 |
| taurine | multiple interactions | EXP | | 6480464 | Taurine inhibits the reaction [Alloxan results in increased expression of CASP9 protein modified form] | CTD | PMID:22138235 |
| taurine | multiple interactions | EXP | | 6480464 | Taurine inhibits the reaction [sodium arsenite results in increased expression of CASP9 protein] | CTD | PMID:20830294 |
| taurocholic acid | multiple interactions | EXP | | 6480464 | Taurocholic Acid inhibits the reaction [Carbon Tetrachloride results in increased activity of CASP9 protein] | CTD | PMID:12388182 |
| taurodeoxycholic acid | increases activity | ISO | RGD:69147 | 6480464 | Taurodeoxycholic Acid results in increased activity of CASP9 protein | CTD | PMID:12773247 |
| taurodeoxycholic acid | multiple interactions | ISO | RGD:69147 | 6480464 | tauroursodeoxycholic acid inhibits the reaction [Taurodeoxycholic Acid results in increased activity of CASP9 protein] | CTD | PMID:12773247 |
| TEMPO | multiple interactions | EXP | | 6480464 | TEMPO inhibits the reaction [Lindane results in increased activity of CASP9 protein] | CTD | PMID:22001173 |
| tert-butyl hydroperoxide | increases cleavage | ISO | RGD:69147 | 6480464 | tert-Butylhydroperoxide results in increased cleavage of CASP9 protein | CTD | PMID:17003459 |
| tert-butyl hydroperoxide | increases expression | ISO | RGD:62159 | 6480464 | tert-Butylhydroperoxide results in increased expression of CASP9 protein | CTD | PMID:20510348 |
| tert-butyl hydroperoxide | multiple interactions | EXP | | 6480464 | Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP9 protein]; more ... | CTD | PMID:19772912 |
| tert-butyl hydroperoxide | increases expression | EXP | | 6480464 | tert-Butylhydroperoxide results in increased expression of CASP9 protein | CTD | PMID:15877105 |
| tert-butyl hydroperoxide | increases cleavage | EXP | | 6480464 | tert-Butylhydroperoxide results in increased cleavage of CASP9 protein | CTD | PMID:15877105 |
| testosterone | decreases expression | ISO | RGD:69147 | 6480464 | Testosterone results in decreased expression of CASP9 protein | CTD | PMID:18030663 |
| testosterone | decreases expression | ISO | RGD:62159 | 6480464 | Testosterone results in decreased expression of CASP9 protein | CTD | PMID:18030663 |
| testosterone | multiple interactions | EXP | | 6480464 | Spironolactone inhibits the reaction [Testosterone inhibits the reaction [Sorbitol results in increased activity of CASP9 protein]] | CTD | PMID:20609311 |
| testosterone | multiple interactions | ISO | RGD:62159 | 6480464 | gingerol inhibits the reaction [Testosterone results in decreased expression of CASP9 protein] | CTD | PMID:18030663 |
| testosterone | multiple interactions | ISO | RGD:69147 | 6480464 | gingerol inhibits the reaction [Testosterone results in decreased expression of CASP9 protein] | CTD | PMID:18030663 |
| tetrachloromethane | increases activity | EXP | | 6480464 | Carbon Tetrachloride results in increased activity of CASP9 protein | CTD | PMID:12388182 |
| tetrachloromethane | multiple interactions | EXP | | 6480464 | Taurocholic Acid inhibits the reaction [Carbon Tetrachloride results in increased activity of CASP9 protein] | CTD | PMID:12388182 |
| thalidomide | decreases activity | ISO | RGD:69147 | 6480464 | Thalidomide results in decreased activity of CASP9 protein | CTD | PMID:15067094 |
| thapsigargin | multiple interactions | ISO | RGD:69147 | 6480464 | Diclofenac inhibits the reaction [Thapsigargin results in increased activity of CASP9 protein] | CTD | PMID:16388830 |
| thapsigargin | increases activity | ISO | RGD:69147 | 6480464 | Thapsigargin results in increased activity of CASP9 protein | CTD | PMID:20130848 PMID:16388830 |
| thapsigargin | increases activity | ISO | RGD:62159 | 6480464 | Thapsigargin results in increased activity of CASP9 protein | CTD | PMID:16018998 |
| thapsigargin | increases activity | ISO | RGD:69147 | 6480464 | Thapsigargin results in increased activity of CASP9 protein | CTD | PMID:16388830 PMID:20130848 |
| thapsigargin | multiple interactions | ISO | RGD:69147 | 6480464 | Melatonin inhibits the reaction [Thapsigargin results in increased activity of CASP9 protein] | CTD | PMID:20130848 |
| thimerosal | increases cleavage | ISO | RGD:69147 | 6480464 | Thimerosal results in increased cleavage of CASP9 protein | CTD | PMID:15869795 |
| thimerosal | increases activity | ISO | RGD:69147 | 6480464 | Thimerosal results in increased activity of CASP9 protein | CTD | PMID:12140745 |
| thimerosal | multiple interactions | ISO | RGD:69147 | 6480464 | Glutathione inhibits the reaction [Thimerosal results in increased activity of CASP9 protein] | CTD | PMID:12140745 |
| thioacetamide | multiple interactions | ISO | RGD:62159 | 6480464 | TXNIP gene mutant form inhibits the reaction [Thioacetamide results in increased activity of CASP9 protein] | CTD | PMID:20713078 |
| thioacetamide | increases activity | ISO | RGD:62159 | 6480464 | Thioacetamide results in increased activity of CASP9 protein | CTD | PMID:20713078 |
| thymidine | multiple interactions | ISO | RGD:69147 | 6480464 | Thymidine inhibits the reaction [Adenosine results in increased activity of CASP9 protein] | CTD | PMID:11570579 |
| thymol | increases activity | ISO | RGD:69147 | 6480464 | Thymol results in increased activity of CASP9 protein | CTD | PMID:21640085 |
| titanium dioxide | increases cleavage | ISO | RGD:69147 | 6480464 | titanium dioxide results in increased cleavage of CASP9 protein | CTD | PMID:20362650 |
| titanium dioxide | increases activity | ISO | RGD:69147 | 6480464 | titanium dioxide results in increased activity of CASP9 protein | CTD | PMID:20541599 |
| titanium dioxide | increases activity | ISO | RGD:62159 | 6480464 | titanium dioxide results in increased activity of CASP9 protein | CTD | PMID:20381595 |
| toluene | affects expression | EXP | | 6480464 | Toluene affects the expression of CASP9 mRNA | CTD | PMID:21827849 |
| topotecan | increases activity | ISO | RGD:62159 | 6480464 | Topotecan results in increased activity of CASP9 protein | CTD | PMID:19812371 |
| topotecan | increases cleavage | ISO | RGD:62159 | 6480464 | Topotecan results in increased cleavage of CASP9 protein | CTD | PMID:19812371 |
| topotecan | multiple interactions | ISO | RGD:62159 | 6480464 | APAF1 promotes the reaction [Topotecan results in increased cleavage of CASP9 protein] | CTD | PMID:19812371 |
| tranexamic acid | multiple interactions | ISO | RGD:69147 | 6480464 | Tranexamic Acid inhibits the reaction [Rotenone results in increased cleavage of CASP9 protein] | CTD | PMID:19539006 |
| trans-resveratrol | multiple interactions | ISO | RGD:69147 | 6480464 | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [[resveratrol results in increased activity of CASP8 protein] which results in increased activity of CASP9 protein] | CTD | PMID:19423619 |
| trans-resveratrol | increases cleavage | ISO | RGD:69147 | 6480464 | resveratrol results in increased cleavage of CASP9 protein | CTD | PMID:18347188 PMID:23152798 |
| trans-resveratrol | increases cleavage | ISO | RGD:69147 | 6480464 | resveratrol results in increased cleavage of CASP9 protein | CTD | PMID:18347188 |
| trans-resveratrol | multiple interactions | ISO | RGD:69147 | 6480464 | resveratrol inhibits the reaction [benzo(e)pyrene results in increased activity of CASP9 protein] | CTD | PMID:19959636 |
| trans-resveratrol | multiple interactions | ISO | RGD:62159 | 6480464 | resveratrol results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:16675471 PMID:18791811 |
| trans-resveratrol | increases cleavage | ISO | RGD:62159 | 6480464 | resveratrol results in increased cleavage of CASP9 protein | CTD | PMID:17872969 PMID:18201729 |
| trans-resveratrol | decreases activity | ISO | RGD:62159 | 6480464 | resveratrol results in decreased activity of CASP9 protein | CTD | PMID:20940732 |
| trans-resveratrol | multiple interactions | ISO | RGD:69147 | 6480464 | sirtinol inhibits the reaction [resveratrol results in increased activity of CASP9 protein] | CTD | PMID:20697895 |
| trans-resveratrol | increases activity | ISO | RGD:69147 | 6480464 | resveratrol results in increased activity of CASP9 protein | CTD | PMID:15827328 more ... |
| trans-resveratrol | multiple interactions | ISO | RGD:69147 | 6480464 | resveratrol results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:16617056 PMID:17636462 |
| trans-resveratrol | multiple interactions | ISO | RGD:69147 | 6480464 | resveratrol inhibits the reaction [MFGE8 protein results in increased activity of CASP9 protein] | CTD | PMID:21505870 |
| trans-resveratrol | decreases activity | ISO | RGD:69147 | 6480464 | resveratrol results in decreased activity of CASP9 protein | CTD | PMID:21505870 |
| trans-resveratrol | multiple interactions | ISO | RGD:69147 | 6480464 | resveratrol results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:12902349 more ... |
| trans-resveratrol | multiple interactions | ISO | RGD:69147 | 6480464 | resveratrol promotes the reaction [Tobacco Smoke Pollution results in increased activity of CASP9 protein] | CTD | PMID:20060927 |
| trans-resveratrol | increases activity | ISO | RGD:69147 | 6480464 | [resveratrol results in increased activity of CASP8 protein] which results in increased activity of CASP9 protein | CTD | PMID:19423619 |
| trans-resveratrol | decreases activity | EXP | | 6480464 | resveratrol results in decreased activity of CASP9 protein | CTD | PMID:20861279 |
| trans-resveratrol | increases activity | ISO | RGD:69147 | 6480464 | resveratrol results in increased activity of CASP9 protein | CTD | PMID:11406544 more ... |
| trans-resveratrol | multiple interactions | ISO | RGD:69147 | 6480464 | [resveratrol co-treated with TNFSF10 protein] results in increased activity of CASP9 protein | CTD | PMID:15763656 |
| trans-resveratrol | multiple interactions | ISO | RGD:69147 | 6480464 | [resveratrol co-treated with Paclitaxel] results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:14749477 |
| trans-resveratrol | multiple interactions | ISO | RGD:69147 | 6480464 | resveratrol promotes the reaction [TNFSF10 protein results in increased cleavage of CASP9 protein] | CTD | PMID:17823925 |
| trans-resveratrol | increases activity | ISO | RGD:69147 | 6480464 | resveratrol results in increased activity of CASP9 protein | CTD | PMID:17050787 |
| trans-resveratrol | multiple interactions | ISO | RGD:62159 | 6480464 | resveratrol inhibits the reaction [4-hydroxy-2-nonenal results in increased activity of CASP9 protein] | CTD | PMID:16322078 |
| trans-resveratrol | multiple interactions | ISO | RGD:62159 | 6480464 | resveratrol results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:16675471 |
| trans-resveratrol | multiple interactions | ISO | RGD:69147 | 6480464 | resveratrol results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:17636462 PMID:16617056 |
| trans-resveratrol | increases cleavage | ISO | RGD:62159 | 6480464 | resveratrol results in increased cleavage of CASP9 protein | CTD | PMID:17872969 |
| trichostatin A | multiple interactions | ISO | RGD:69147 | 6480464 | [bortezomib co-treated with trichostatin A] results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:16904634 |
| trichostatin A | multiple interactions | ISO | RGD:69147 | 6480464 | trichostatin A promotes the reaction [CASP9 protein affects the localization of BID protein] | CTD | PMID:12556448 |
| trichostatin A | multiple interactions | ISO | RGD:69147 | 6480464 | trichostatin A results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:16010430 |
| trichostatin A | multiple interactions | ISO | RGD:69147 | 6480464 | [trichostatin A co-treated with bortezomib] results in increased cleavage of CASP9 protein | CTD | PMID:21345073 |
| trimethylenediamine | multiple interactions | ISO | RGD:69147 | 6480464 | [Copper binds to Isatin binds to trimethylenediamine] which results in increased cleavage of CASP9 protein | CTD | PMID:17327230 |
| troglitazone | multiple interactions | ISO | RGD:69147 | 6480464 | GSK3B protein affects the susceptibility to [troglitazone results in increased expression of CASP9 protein]; more ... | CTD | PMID:20540935 |
| troglitazone | increases expression | ISO | RGD:69147 | 6480464 | troglitazone results in increased expression of CASP9 protein | CTD | PMID:20540935 |
| troglitazone | increases activity | ISO | RGD:69147 | 6480464 | troglitazone results in increased activity of CASP9 protein | CTD | PMID:14508522 |
| tryptamine | multiple interactions | EXP | | 6480464 | tryptamine analog inhibits the reaction [Indomethacin results in increased activity of CASP9 protein] | CTD | PMID:22157011 |
| tunicamycin | multiple interactions | ISO | RGD:69147 | 6480464 | Diclofenac inhibits the reaction [Tunicamycin results in increased activity of CASP9 protein] | CTD | PMID:16388830 |
| tunicamycin | increases activity | ISO | RGD:69147 | 6480464 | Tunicamycin results in increased activity of CASP9 protein | CTD | PMID:16388830 |
| tunicamycin | increases cleavage | ISO | RGD:69147 | 6480464 | Tunicamycin results in increased cleavage of CASP9 protein | CTD | PMID:17553788 |
| tunicamycin | increases cleavage | ISO | RGD:62159 | 6480464 | Tunicamycin results in increased cleavage of CASP9 protein | CTD | PMID:14747384 |
| urethane | multiple interactions | ISO | RGD:62159 | 6480464 | [Urethane co-treated with Freund's Adjuvant] results in increased expression of CASP9 mRNA | CTD | PMID:12400877 |
| urethane | increases expression | ISO | RGD:62159 | 6480464 | Urethane results in increased expression of CASP9 mRNA | CTD | PMID:12400877 |
| ursodeoxycholic acid | multiple interactions | ISO | RGD:69147 | 6480464 | Ursodeoxycholic Acid inhibits the reaction [Nitroprusside results in increased activity of CASP9 protein] | CTD | PMID:22178905 |
| valproic acid | affects expression | ISO | RGD:62159 | 6480464 | Valproic Acid affects the expression of CASP9 mRNA | CTD | PMID:17963808 PMID:17292431 |
| valproic acid | affects expression | ISO | RGD:62159 | 6480464 | Valproic Acid affects the expression of CASP9 mRNA | CTD | PMID:17292431 PMID:17963808 |
| valproic acid | increases expression | ISO | RGD:62159 | 6480464 | Valproic Acid results in increased expression of CASP9 mRNA | CTD | PMID:21427059 |
| wortmannin | multiple interactions | ISO | RGD:69147 | 6480464 | ABT-737 promotes the reaction [wortmannin promotes the reaction [celecoxib results in increased cleavage of CASP9 protein]] | CTD | PMID:20104024 |
| wortmannin | multiple interactions | ISO | RGD:69147 | 6480464 | wortmannin promotes the reaction [Doxorubicin results in increased cleavage of CASP9 protein]; more ... | CTD | PMID:17935137 |
| ytterbium | increases activity | ISO | RGD:69147 | 6480464 | Ytterbium analog results in increased activity of CASP9 protein | CTD | PMID:19632212 |
| zinc atom | multiple interactions | ISO | RGD:69147 | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of CASP9 mRNA | CTD | PMID:18593933 |
| zinc(0) | multiple interactions | ISO | RGD:69147 | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of CASP9 mRNA | CTD | PMID:18593933 |
| zoledronic acid | multiple interactions | ISO | RGD:69147 | 6480464 | zoledronic acid results in increased cleavage of and results in increased activity of CASP9 protein | CTD | PMID:12799645 |
| zoledronic acid | increases activity | ISO | RGD:69147 | 6480464 | zoledronic acid results in increased activity of CASP9 protein | CTD | PMID:19036117 |
| zoledronic acid | multiple interactions | ISO | RGD:62159 | 6480464 | [zoledronic acid co-treated with Doxorubicin] results in increased activity of CASP9 protein | CTD | PMID:19789217 |